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Abstract 
 Cells are exposed to a variety of environmental and physiological changes including 
temperature, pH and nutrient availability. These changes cause stress to cells, which results 
in protein misfolding and altered cellular protein homeostasis. How proteins fold into their 
three-dimensional functional structure is a fundamental biological process with important 
relevance to human health. Misfolded and aggregated proteins are linked to multiple 
neurodegenerative diseases, cardiovascular disease and cystic fibrosis. To combat 
proteotoxic stress, cells deploy an array of molecular chaperones that assist in the repair or 
removal of misfolded proteins. 
 Hsp70, an evolutionarily conserved molecular chaperone, promotes protein folding 
and helps maintain them in a functional state. Requisite co-chaperones, including nucleotide 
exchange factors (NEFs) strictly regulate and serve to recruit Hsp70 to distinct cellular 
processes or locations. In yeast and human cells, three structurally non-related cytosolic 
NEFs are present: Sse1 (Hsp110), Fes1 (HspBP1) and Snl1 (Bag-1). Snl1 is unique among 
the cytosolic NEFs as it is localized at the ER membrane with its Hsp70 binding (BAG) 
domain exposed to the cytosol. I discovered that Snl1 distinctly interacts with assembled 
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ribosomes and several lines of evidence indicate that this interaction is both independent of 
and concurrent with binding to Hsp70 and is not dependent on membrane localization. The 
ribosome-binding site is identified as a short lysine-rich motif within the amino terminus of 
the Snl1 BAG domain distinct from the Hsp70 interaction region. In addition, I demonstrate 
ribosome association with the Snl1 homolog in the pathogenic fungus, Candida albicans and 
localize this putative NEF to a perinuclear/ER membrane, suggesting functional conservation 
in fungal BAG domain-containing proteins. As a first step in determining specific domain 
architecture in fungal BAG proteins, I present the preliminary steps of protein purification 
and analysis of the minimal Hsp70 binding region in in both S.cerevisiae and C. albicans 
Snl1. 
Contrary to previous in vitro evidence which showed the Fes1 NEF to interact with 
both cytosolic Hsp70s, Ssa and Ssb, Fes1 is shown to interact specifically with Ssa when 
expressed under normal cellular conditions in S. cerevisiae. This is the first reported evidence 
of Hsp70 binding selectivity for a cytosolic NEF, and suggests a possible mechanism to 
achieve specificity in Hsp70-dependent functions. Taken together, the work presented in this 
dissertation highlights the striking divergence among Hsp70 co-chaperones in selecting 
binding partners, which may correlate with their specific roles in the cell. 
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The word ‘protein’ first appeared in scientific literature in 1838 and was derived from 
the Greek adjective proteios, meaning “of the first rank or position.” Proteins are the most 
abundant molecules in biology apart from water and form a versatile group of 
macromolecules in cells that play essential roles in almost all biological processes. For 
example, they work as enzymes, facilitate transport, maintain structural integrity of a cell and 
are key components in immune function, signal transduction and regulation. 
The cellular stress response 
The cellular environment where proteins reside is constantly in flux with regard to 
nutrient status, temperature, exposure to toxic molecules, pressure, pH, etc. The cellular 
stress response is an evolutionarily highly conserved mechanism that protects cells from 
detrimental effects caused by environmental fluctuations. For example, sudden changes in 
salt (NaCl) concentrations outside the cell can cause a dramatic loss in intracellular water 
content thereby damaging cellular proteins. To deal with this stress, cells respond by rapidly 
stimulating the expression of proteins involved in sodium transport systems to adjust the 
balance and to counteract the toxic effects of sodium ions. Continued exposure to stress also 
interferes with normal functions of the cell by altering the biochemical properties of proteins, 
which can facilitate their misfolding, unfolding or aggregation. Thus, the cellular stress 
response represents a mechanism to sense the stress and mount a response to negate or adapt 
to its toxic effects.  
The stress response to temperature increase (heat stress) is conserved among all 
organisms and a prominent feature includes the induction of a gene expression program 
called the heat shock response (HSR) (110, 147). Much of the cellular response to stress is 
similar, regardless of the kind of stressor, and activation of HSR can often occur during other 
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stressors including pathophysiological states and oxidative damage. This adaptation 
mechanism is well studied and results in metabolic remodeling, transient reduction in growth 
and global transcriptional changes. One characteristic of HSR is the induction of a number of 
cytoprotective genes encoding heat shock proteins (HSPs). Many HSPs function as molecular 
chaperones that bind partially unfolded proteins and protect them from aggregation or 
degradation. Much of what we know about HSR in eukaryotic cells has been learned through 
studies using the budding yeast, Saccharomyces cerevisiae due to its facile genetics, 
biochemistry and cell biology as well as the numerous genome-wide and proteome-wide 
tools that have become available in the last few years. Yeast cells grow optimally within a 
narrow temperature range (25°C – 30°C) but a temperature change to 37°C, activates the 
yeast HSR (147).  
Stress responses in Saccharomyces cerevisiae 
In eukaryotes, the heat shock transcription factor (HSF) protein family is the main 
modulator of HSR (85). In evolutionary diverse organisms such as unicellular yeasts and 
metazoans such as nematodes and fruit flies, there exists a single essential heat shock factor 
(Hsf1) that activates the transcription of hsp genes. In contrast, vertebrates have evolved a 
family of four members, HSF1-4, of which HSF1 is the equivalent of the fungal and 
metazoan HSF1 (81). In mammals, while HSF1 is the ubiquitous heat stress response 
activator, HSF2 is developmentally regulated and important for neuronal specification. HSF3 
has been characterized only in avian species while HSF4 is cell type-specific associated with 
expression of crystallines in the lens of the eye (93). Hsf1 recognizes a pentameric heat shock 
transcription element (HSE) consisting of repeating units of the sequence nGAAn, where “n” 
can be any nucleotide, in promoters of target genes and activates their transcription (12, 142). 
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Under normal conditions in mammalian cells, Hsf1 exists as a monomer but during stress, 
Hsf1 gets rapidly trimerized, accumulates in the nucleus and binds to HSEs. In contrast, yeast 
Hsf1 is constitutively trimerized, nuclear-associated and bound to high-affinity HSEs under 
normal and additional HSEs during stress conditions. The target genes of Hsf1 include 
components of the protein quality control machinery (ubiquitin proteasome system) and 
molecular chaperones.  
In addition to Hsf1-mediated stress response, a parallel pathway in S. cerevisiae 
responds to a variety of cellular and environmental stresses including oxidative and osmotic 
stress and nitrogen starvation. This pathway referred to as “general stress response” is 
governed by two highly related transcription factors, Msn2 and Msn4 (77, 124). These 
factors bind to an invariant five base pair sequence element (CCCCT) called the “stress 
response element” (29). The response mediated by Msn2/4 is generally transient and the 
strength and duration of the response is dependent on the strength of the stresses. (42). 
Although many of the genes induced by Msn2/4 are distinct from those regulated by Hsf1, 
there are a few exceptions such as HSP104, which contains both HSE and STRE elements in 
their promoters. Hsp104 in yeast cells, a member of the Hsp100 family of chaperones helps 
to disassemble protein aggregates that accumulate in the cell due to stress (102). 
Transcriptional activation of HSP104 is obtained through cooperation between both Msn2/4 
and Hsf1 systems although either factor can activate the promoter alone. Thus, cells have 
evolved back-up measures for certain cytoprotective genes whose activity is essential for 
proper stress response and cannot be replaced or bypassed by another gene (117, 118).  
At any given time in the cell, processes that involve proteins must be properly 
regulated to efficiently maintain cellular functions. This requires that all cellular protein 
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concentrations, conformations, binding interactions, localization and removal must be 
coordinately regulated, and the balance between them is required to maintain protein 
homeostasis or “proteostasis” (Figure1-1) (6). One of the major consequences of cellular 
stress is intracellular protein unfolding and misfolding, which can result in their 
accumulation in cells. Although it is still unclear how a cell senses stresses like temperature 
change and transduces this signal to Hsf1, protein unfolding caused by this stress is sufficient 
to activate HSR. However, it is not known if this is the main signal for HSR activation during 
other stresses.  
Cellular proteostasis 
“Proteostasis” is defined as the state of dynamic equilibrium in the cell where protein 
synthesis and folding is balanced with degradation (Figure 1-1). Genetic screens performed 
in model organisms such as S. cerevisiae, C. elegans and D. melanogaster identified factors 
that maintain proteostasis in the cell that either promote protein folding or protein 
degradation (136). The factors forming the proteostasis network (PN) include molecular 
chaperones, subunits of the proteasome, components of the autophagy system, and Hsf1. The 
PN coordinates molecular pathways including protein synthesis, folding, transport and 
clearance and thus has the task of surveying the cellular proteome for proteins that are unable 
to achieve their native conformation (6). This suggests that a set of factors function in 
response to imbalances in proteostasis and represent a core of the PN. Despite the robust 
regulation of the PN during stress conditions, chronic expression of aggregation-prone 
proteins escape its vigilance and causes accumulation of misfolded and damaged proteins 
that in turn overburdens the proteostasis machinery and can lead to cell death.  
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A challenge facing the PN is the high volume-occupied space in the cell. Non-specific 
influences of steric repulsions on intracellular reactions and processes, also known as 
‘macromolecular crowding’ occur in this space. In the ‘crowded’ environment of a cell (total 
cytosolic protein concentrations reach 300-400 g/l) the free space that a protein molecule can 
move is limited and will affect its stability and reactions (33, 34) Although this may increase 
the interactions between macromolecules, crowding can also enhance the tendency of non-
native and structurally flexible proteins to aggregate (34). In addition, the constant 
production of newly synthesized proteins provides a large protein-folding challenge in this 
crowded environment, as is the recognition of damaged and aggregated proteins that must be 
targeted for degradation. Thus, factors that can facilitate proper molecular interactions within 
a protein and between proteins are vital to maintain proteostasis. These include molecular 
chaperones (51).  
Regulation of PN occurs through signaling pathways that directly control the 
concentration, activities and distribution of components of the PN. Signaling pathways 
regulate protein synthesis, folding, transport, aggregation, disaggregation and clearance. 
These include (i) the unfolded protein response (153), which senses the folding capacity of 
the ER, (ii) the HSR, (1) pathways that influence Ca2+ levels in the ER that in turn regulate 
the folding of N-linked glycoproteins in the ER via Ca2+-sensitive chaperones (calnexin, 
calreticulin) and (iv) cell death pathways. These signaling pathways control the capacity of 
the cellular proteome through transcriptional, translational and post-translational processes 
by balancing the biogenesis and folding of proteins with protein degradation. When the PN is 
severely compromised in the case of early and late- onset genetic diseases (see below), 
signaling attempts to rebalance proteostasis fails and can activate cell death pathways, 
! 7!
 
 
 
 
 
 
 
 
 
 
FIGURE 1-1. Model of proteostasis. Shown are the various states of a protein after their 
synthesis. Maintenance of the balance between protein synthesis and folding with protein 
degradation is termed “proteostasis.” 
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FIGURE 1-1. Model of proteostasis   
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targeting the cell for destruction. Any imbalance in the PN is associated with diseases that 
cause metabolic disorders, neurodegeneration, cancer and cardiovascular disease. 
Thus, understanding each component of the PN and how they function cooperatively within 
this network can aid in future manipulations of these components for therapeutic purposes.  
Protein aggregation diseases 
 
When a protein fails to fold properly due a change in its sequence and/or its 
concentration or if components of the PN are compromised, a breakdown in cellular protein 
homeostasis occurs. Conformational diseases associated with improper folding can be 
categorized as gain- or loss-of-function disorders. Gain-of-function diseases arise due to 
proteotoxicity caused by accumulation of protein aggregates in the cell. These include 
Parkinson’s disease (PD), Huntington’s disease, amyotrophic lateral sclerosis (ALS) and 
Alzheimer’s disease (AD) (23, 57, 86, 87). Loss-of-function diseases on the other hand 
include cystic fibrosis and Gaucher disease and are caused by inherited mutations that lead to 
inefficient protein folding and excessive degradation (17, 112). 
AD affects millions of older individuals worldwide and is a direct outcome of protein 
aggregation. AD is a result of neuron degeneration in the forebrain and hippocampus region, 
which is caused by the accumulation of β-amyloid plaques and neurofibrillary tangles. 
Plaques are composed of aggregated amyloid β (Aβ) peptides. Aβ monomers are soluble and 
largely helical in structure, however, at sufficiently high concentrations, they undergo 
dramatic conformational changes to form β-sheet structures. Amyloid aggregation and their 
deposition outside neurons is driven by the intrinsic aggregating property of the mutant Aβ 
form (111). Neurofibrillary tangles are composed of protein tau, a microtubule associated 
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protein. Hyperphosphorylation of tau results in its propensity to aggregate inside nerve cells 
and contributes to disease pathogenesis (133).  
PD is also an outcome of protein aggregation. Two mutations (A53T and A30P) in 
the α-synuclein protein accelerates the formation of amyloid fibers, which self-associates and 
forms an oligomeric species (Lewy bodies) inside nerve cells resulting in proteotoxicity (71). 
α-synuclein exists in two structurally distinct populations in cells: an α-helical membrane-
bound and disordered free cytosolic form. Membrane-bound forms have an increased 
tendency to aggregate, which act as seeds to accelerate the aggregation of the cytosolic form.  
HD is caused by a mutation in a gene that results in an expansion of CAG repeats 
coding for polyglutamine (polyQ) at the amino-terminus of protein Huntington (Htt). 
Aggregation of Htt within neuronal cells (inclusion bodies) leads to their degeneration. 
Interestingly, HD occurs in individuals when there are 35 or more CAG repeats in the gene 
coding for the Htt protein. Below this number, individuals are unaffected, suggesting a 
correlation between polyQ length and disease progression (55).  
ALS, also called Lou Gehrig’s disease is caused by a mutation in a gene, TDP-43, 
which is expressed in the brain and spinal cord. It has been reported that 19 missense and one 
truncating mutation to this gene occurs in ALS patients and progressive accumulation and 
aggregation of this gene product contributes to the disease due to a failure of the proteasome 
to recycle damaged proteins (95).  
In addition to protein misfolding diseases related to the nervous system, other 
diseases that are caused by protein aggregation include cystic fibrosis and cardiovascular 
disease. Cystic fibrosis occurs as a result of mutations in a gene that encodes a chloride ion 
channel called cystic fibrosis transmembrane conductance regulator (CFTR) in pulmonary 
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epithelial cells. A mutation A508F in the protein alters the ability of the first nucleotide-
binding domain of CFTR to fold properly and is thus degraded. This prevents the trafficking 
of this protein to the apical membrane in affected epithelial cells (113).  
Accumulation of pre-amyloid oligomers in cardiomyocytes have been observed in 
human heart failure samples. To test whether protein aggregation in these cells is the cause 
for heart failure, transgenic mice were created expressing long and short polyQ repeats. A 83 
CAG stretch caused intracellular accumulation of oligomers and these aggregates lead to 
cardiomyocyte death and heart failure in a murine model, confirming that heart failure can be 
related to protein aggregation (103). Diseases caused by protein aggregation in cells highlight 
the importance of understanding the PN and the functional roles of its components during 
protein aggregation (92).  
Roles of chaperones in maintaining proteostasis 
The protein folding function of the proteostasis network is accomplished by 
molecular chaperones that bind to intermediate and transition states of proteins. The 
regulation of genes encoding molecular chaperones is critical to maintain proteostasis and to 
restore a balance in the cellular proteome during stress. The involvement of PN in protein 
conformational diseases is underscored by a decrease in toxicity when individual molecular 
chaperones are overexpressed in various cell-based and animal models. Chaperones contain 
HSEs in their promoter sequences and hence are principally regulated by Hsf1. Cellular 
stress increases the demand for the folding machinery and the activation of Hsf1 induces the 
expression of genes encoding multiple chaperones. Based on their apparent molecular 
weights, chaperones can be classified into five protein families: the small Hsps (sHsps), 
which lack ATPase activity, and the ATPases Hsp100, Hsp90, Hsp70 and Hsp60. 
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The sHsps represent a diverse family of proteins with limited chaperone activity. 
They are present either transiently or stably in high molecular weight complexes, where they 
interact with unfolded substrates at a 1:1 monomer-to-substrate ratio (161). Instead of 
preventing aggregation of misfolded proteins, sHsps appear to co-aggregate with their 
substrates forming oligomeric complexes within the cell. Refolding of sHsp-associated 
substrates requires the action of ATP-dependent chaperones. Two well studied sHsps in 
yeast, Hsp26 and Hsp42 are both required to promote protein solubility during  cellular stress 
and to maintain proteostasis during heat shock (20).  
The representative member of the Hsp100 class in yeast is Hsp104, which forms 
hexameric rings with a large (~15 angstrom) central channel. Hsp104 is unique among the 
other chaperones as it is capable of extracting misfolded proteins from large aggregates. 
Hsp104 cannot refold proteins alone and requires the function of Hsp70 to return proteins to 
their native conformation. Cells lacking HSP104 are highly sensitive to heat shock 
suggesting that this chaperone is absolutely required for maintaining proteostasis during heat 
stress (119). Interestingly, human cells lack a Hsp104 homolog but when yeast Hsp104 is 
expressed in human cells, it confers thermoprotection (21). This suggests that higher 
eukaryotes have evolved another strategy to remove large protein aggregates in the cell or 
utilize a combination of different chaperones to achieve this. 
The Hsp90 chaperone family binds a selective group of client proteins, unlike Hsp70 
that can associate with nearly any partially unfolded protein it encounters. These clients 
require Hsp90 for the final stages of native folding after initial interactions with Hsp70, thus 
linking these two chaperone families. Client proteins include those involved in signal 
transduction pathways such as kinases (yeast Ste11 analogous to mammalian Raf), steroid 
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receptors (glucocorticoid receptor) and also transcription factors (Hsf1) (104, 167). In yeast, 
Hsp90 is encoded by two genes HSC82 and HSP82, which are constitutively and inducibly 
expressed, respectively, upon heat shock (14).  
The Hsp70 chaperone family interacts with proteins at all stages in their lifetimes 
starting from their biogenesis at the ribosome to their final native state (40). Hsp70 and its 
cofactors, functions and locations in the cell will be discussed in more detail later in this 
chapter.  
The Hsp60 chaperone family, also called chaperonins, form double-ring complexes 
and fold proteins within a central cavity in a nucleotide-dependent manner. There are two 
main groups of chaperonins, group I includes E. coli GroEL consisting of a seven-member 
ring and group II present in eukaryotes called TriC having eight or nine member rings (35, 
41). Chaperonins encapsulate unfolded proteins, one molecule at a time and alleviates 
macromolecular crowding of certain proteins, thus preventing their aggregation during their 
folding process. The major substrates of TriC include the cytoskeletal proteins, actin and 
tubulin. 
Chaperones thus play diverse roles in the PN by regulating protein folding, assisting 
the assembly and disassembly of macromolecular complexes and to regulate translocation 
with cellular organelles. The yeast genome contains chaperones of these families: 7 sHsps, 
14 belonging to the chaperonin complex, 2 Hsp90s, 14 Hsp70s, 1 Hsp60 and 3 Hsp104s (48). 
Thus, it is the function of the cellular PN to regulate the plethora of chaperones during 
normal and especially stress conditions.   
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Roles of chaperones in human diseases 
 A number of studies show molecular chaperones associate with misfolded disease 
proteins and prevent their aggregation. For example, in a Drosophila model, overexpression 
of Hsp70 and its co-chaperone Hsp40 strongly protected neurons that expressed the mutant 
form of the Htt protein (157). Similarly, in a C. elegans model, overproduction of Hsp104 
reduced toxic cellular effects caused by mutant Htt (120). In a PD cell model, overexpression 
of Hsp70 or its co-chaperone Hdj1 decreased the number of cells that contain Lewy bodies 
(abnormal protein aggregates that develop inside nerve cells) by more than 50% (80). Hsp70 
chaperones have also been found to associate with Lewy bodies in affected brain tissues of 
patients with PD (82). Hsp27 preferentially interacts with the hyperphosphorylated tau 
mutant in human brain samples, and cell culture experiments show that increasing the 
production of this chaperone can decrease hyperphosphorylated tau levels, which in turn 
suppresses tau-mediated cell death (133). In addition, in vitro evidence has established a 
functional interaction between tau, Hsp70 and Hsp90 (30). Two parallel lines of investigation 
that decreased the amount of Hsp70/Hsp90 by RNA-mediated interference or induced the 
amounts of Hsp70/Hsp90 had opposite effects on tau. The former increased the aggregated 
state of tau while the latter decreased the incidence of aggregation, confirming the role of 
these two chaperones in maintaining the native fold and function of tau (30). 
The evidence that chaperones associate with aggregating proteins involved in the 
progression of certain diseases suggests that the cellular proteostasis machinery is activated 
to help prevent aggregation of misfolded proteins. Consistent with this, the accumulation of 
cellular aggregates is known to trigger the HSR, which in turn induces the expression of 
chaperones. This was shown by treating cells under normal conditions with puromycin, 
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which leads to premature nascent chain termination or AZC, an amino acid analog of proline, 
which prevents normal folding. HSR was induced as a result of unfolded proteins in the cell 
(47). In the case of a polyQ-containing disease protein, Hsp70 and Hsp40 expression was 
shown to divert the protein away from its aggregation-prone pathway resulting in the 
formation of a less stable aggregate form that is more amenable to folding (88, 122).  
 Alternatively, mutations that cause alterations in genes encoding chaperones may also 
cause some human diseases and are likely the result of a loss-of-function of chaperone-
dependent substrate proteins. For example, a missense mutation in the mitochondrial 
chaperonin Hsp60 that causes a loss of chaperone function, results in spastic paraplegia 
SPG13 (37). This disease is characterized by progressive weakness of the lower limbs but it 
is unclear why a dysfunction in Hsp60 affects only motor neurons of the lower limbs. It is 
possible that folding of a specific Hsp60-dependent substrate is affected in these cells. 
Studies involving α-crystallin, a member of the sHsp family showed that missense 
substitutions in a conserved arginine residue in the core domain of each of its subunits lead to 
disease progression. Cataracts occur when the mutation is in the A subunit of α-crystallin and 
desmin-related myopathy when the substitution is in the B subunit (153).  
 Since structural defects in a variety of proteins can lead to a disease state, the proper 
functioning of molecular chaperones in the PN is needed to maintain structural integrity of 
cellular proteins. 
Ribosome-associated chaperones 
Protein synthesis on the ribosome is the first stage of the proteostasis network where 
multiple factors directly bind to ribosomes and interact with nascent polypeptides. These 
include chaperones, processing enzymes that modify the N-termini of nascent polypeptides 
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and targeting factors such as the signal recognition particle (SRP) that initiate the delivery of 
secretory proteins to the ER membrane for translocation (69). During polypeptide elongation 
on the ribosome, approximately four and 20 amino acids are added per second in eukaryotes 
and bacteria, respectively. The challenge facing the PN is that sequence information of a 
nascent polypeptide is incomplete and continuously changing depending on the translation 
rate and therefore polypeptides are exposed in partially folded, aggregation-prone states for 
relatively long periods of time until the entire protein has been synthesized. Thus, cells utilize 
chaperones to protect nascent polypeptides during translation. Chaperones involved in de 
novo folding of cytosolic proteins can be classified into two groups. The first group includes 
chaperones that directly interact with the ribosome and emerging polypeptide to facilitate 
early peptide folding, and the second group consists of chaperones of the Hsp70 and Hsp60 
families that bind polypeptides downstream of their ribosome-associated counterparts. The 
coordinated function of both groups forms a robust network that safeguards newly 
synthesized proteins from aggregation.  
E. coli Trigger factor (TF) is the best-understood ribosome associated chaperone and 
its role in cotranslational protein folding is well characterized. TF is present only in bacteria 
and chloroplasts and contains multiple binding sites that provide several hydrophobic contact 
points for an unfolded polypeptide chain. In addition, the N-terminal domain of TF contains a 
linker domain motif that mediates binding to large subunit ribosomal protein Rpl23 situated 
near the ribosome exit tunnel, which ideally positions TF to associate with emerging 
polypeptide chains (70). Recent data from ribosome profiling experiments showed that TF is 
recruited only after a nascent peptide reaches a length of ~100 amino acids (97). This finding 
suggests that factors such as processing enzymes that remove the formyl moiety and the 
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initiator methionine from the N-termini of nascent chains have access to nascent peptides 
before the chaperone is recruited to the ribosome. 
In eukaryotes, a TF homolog has not been identified but there are two separate 
protein complexes that bind to the ribosome and nascent polypeptides: (i) nascent chain 
associated complex (NAC) and (ii) ribosome associated complex (RAC).  
(i) NAC in yeast and higher eukaryotes forms a α-β heterodimer that associates with 
ribosomes using a ribosome-binding motif (in the β subunit) consisting of a short stretch of 
positively charged amino acids. Crosslinking experiments localized the NAC binding site on 
the ribosome to large subunit ribosomal protein Rpl25, the yeast homolog of bacterial Rpl23, 
suggesting a conserved binding site on the ribosome for these ribosome-associated factors 
(105, 158). Importantly, ribosome association is a prerequisite for NAC interaction with 
nascent chains. In contrast to higher eukaryotes, yeast has three NAC subunits: two β-NAC 
(Egd1 and Btt1) and one α-NAC (Egd2), which result in Egd1-Egd2 and Btt1-Egd2 
heterodimers. Btt1 containing heterodimers bind ribosomes that translate mitochondrial or 
ribosomal proteins while the Egd1-Egd2 heterodimer bind ribosomes that translate metabolic 
enzymes and secretory and membrane proteins (26).  
(ii) In yeast and mammals, RAC forms a heterodimer between an Hsp40, Zuo1 (MPP11 in 
mammals) and an Hsp70, Ssz1 (Hsp70L1 in mammals). In addition, fungal species contain 
another ribosome-associated Hsp70, Ssb, which functions together with RAC. Higher 
eukaryotes lack a ribosome associated Hsp70 and hence utilize cytosolic Hsp70 together with 
mammalian RAC to facilitate folding of nascent polypeptides. Zuo1 requires stable 
association with Ssz1 to act as a co-chaperone of Ssb and contains a ribosome binding region 
that allows RAC to bind near ribosome protein Rpl31, situated at the ribosome exit tunnel 
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(106). Although direct association of RAC with nascent chains has not been shown, RAC is 
required for stimulating the binding of Ssb to nascent chains. 
Experimental evidence shows that NAC and Ssb associate with aggregated, insoluble 
amyloid-like fibers and insoluble polyQ repeat proteins artificially expressed in mammalian 
and yeast cells respectively (98, 156). Although the physiological significance of these 
findings is not known, the ability of these proteins to play a role in protein biogenesis at the 
ribosome and associate with cellular aggregates suggests that ribosome-associated 
chaperones are potent modulators of protein synthesis and folding and represent key elements 
in the proteostasis network.  
The Hsp70 family of chaperones 
The 70-kDa family of heat shock proteins (Hsp70s) is evolutionarily conserved and 
assists in a wide range of cellular functions including protection of nascent polypeptides as 
they emerge from the ribosome, targeting and translocation of proteins, and either refolding 
damaged proteins or assisting in their degradation. Hsp70s function by binding to solvent 
exposed hydrophobic residues that are normally buried in a properly folded protein and 
ensure that nascent or misfolded proteins do not aggregate as a result of improper folding 
(Figure 1-2).  
Hsp70s are functionally divided into two domains: a ~44 kDa N-terminal nucleotide-
binding domain (NBD) joined by a conserved linker to a ~25 kDa C-terminal substrate-
binding domain (SBD), which is further subdivided into the (15 kDa) β-sandwich subdomain 
and the C-terminal α-helical subdomain. The NBD is divided into four subdomains, IA, IB, 
IIA and IIB (Figure 3-1, green). The region between subdomains IIA and IIB is flexible, 
which allows subdomain IIB to rotate at this hinge region relative to the other subdomains 
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(38). The substrate binding characteristics of the SBD are governed allosterically by the 
nucleotide status of the NBD (154). The NBD has two lobes with an opening between them 
where the nucleotide binds. The β-sandwich subdomain of the SBD forms a base with a 
hydrophobic groove for polypeptide binding and the α-helical subdomain forms a lid over 
the polypeptide binding site. The SBD can bind a short hydrophobic section (~ seven 
residues) of a polypeptide chain in an extended conformation (116, 168). In the ATP-bound 
state, Hsp70 has a low affinity for the substrate as a result of increased flexibility between the 
base and lid of the SBD and effectively opens the peptide-binding site. Hydrolysis of ATP to 
ADP results in a change in the SBD, which conforms it to a more closed state and hence 
increases substrate affinity. Ultimately, the release of ADP and replacement with ATP 
confers the release of the folded or partially folded substrate, allowing the cycle to repeat 
(Figure 1-3). Two major classes of Hsp70 co-chaperones interact with the NBD of Hsp70 to 
regulate its protein folding function. The Hsp40/DnaJ family of proteins share a common ~70 
amino acid J-domain that mediates binding to Hsp70 and activation of Hsp70’s weak ATPase 
activity. Nucleotide exchange factors (NEFs) catalyze ADP-ATP exchange, which is a 
critical step in the cycle that releases the substrate and recycles Hsp70 back to its ATP-
binding conformation. (Figure 1-3) The role of the NEFs will be discussed below. 
As shown in Table1-1, Hsp70 family members are present in the cytoplasm, ER and 
mitochondria. In the mitochondria, there exists a “specialized” Hsp70 that operates with a 
“general” Hsp70. The general Hsp70 in the yeast mitochondrial matrix, Ssc1, is involved in 
refolding of protein substrates after import into the mitochondria, while the specialized 
Hsp70, Ssq1 is required specifically for maturation of iron-sulfur cluster-containing proteins. 
In humans, there exists one mtHsp70 (mitochondrial Hsp70), which is 65% homologous to 
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the yeast Ssc1 (11). Kar2 present in the yeast ER performs general Hsp70 functions in this 
compartment. BiP, the human homolog of Kar2 performs the same functions of facilitating 
substrate translocation into the ER lumen and their subsequent folding (53, 91). The cytosol 
of yeast contains several Hsp70s and will be discussed below. 
The cytosolic Hsp70s in yeast        
 In S. cerevisiae, seven cytosolic Hsp70s are classified into two major groups: a) the 
canonical Ssa1, Ssa2, Ssa3 and Ssa4 proteins and b) the ribosome-associated Ssb1, Ssb2 and 
Ssz1 proteins. The Ssa and Ssb families share 60% amino acid identity between families but 
have distinct, non-overlapping functions in vivo (13). Constitutive expression of SSA and SSB 
genes do not complement each other’s deletion phenotypes, indicating that these two classes 
of Hsp70s have evolved distinct functions (62, 107). The Ssa proteins are highly homologous 
and differ in their expression patterns with Ssa1/2 being constitutively expressed during 
normal vegetative growth and Ssa3/4 being induced only upon stress (160). Deletion of all 
four Ssa proteins is lethal to the cell but the constitutive expression of any one of them can 
complement lethality, suggestive of redundant functions for these chaperones (160). Cells 
lacking both Ssa1 and Ssa2 are slow growing and thermosensitive at 37 °C (160). At this 
temperature, Ssa3 and Ssa4 are induced but do not alleviate the slow growth of the 
ssa1Δssa2Δ strain suggesting that Ssa3/4 cannot fully complement the loss of Ssa1/2 despite 
the high degree of similarity among them. The protein folding capacity of Ssa proteins is a 
well-known function, and cells lacking Ssa proteins are defective in their abilities to fold the 
model protein firefly luciferase (151). Also, it was previously believed that Ssa proteins 
interacted with their substrate posttranslationally. However, deletion of ribosome-associated 
Ssb increased the co-translational interaction of nascent polypeptides with Ssa1,
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FIGURE 1-2. Model of chaperone action in protein folding. Hsp70 family of chaperone 
proteins represented by blue circles bind to unfolded polypeptides preventing 
misfolding/aggregation, while promoting active folding to the native conformation. 
! 22!
FIGURE 1-2. Model of chaperone action in protein folding  
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FIGURE 1-3. Hsp70 folding cycle. ATPase-dependent cycle of Hsp70 chaperone 
illustrating its dependence on ATPase activity and nucleotide exchange activity.    
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FIGURE 1-3. Hsp70 folding cycle   
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suggesting that Ssa chaperones can interact with nascent chains emerging from the ribosome 
(163). This corroborates with data showing Ssa interacting with two ribosome-associated 
factors, Sis1, an Hsp40 and poly(A)-binding protein Pab1, providing a direct link between 
Ssa and translating ribosomes (56). The Ssa family is also involved in protein translocation 
across cellular membranes, including the vacuole, the nucleus, mitochondria and the ER (28, 
79, 121, 135). Cells lacking Ssa function are defective in translocation of the yeast 
pheromone, alpha-factor and the β-subunit of the mitochondrial F1-ATP-ase. Another role of 
Ssa in protein degradation is exemplified using a model substrate for proteasomal 
degradation, a mutated cytosolic form of the vacuolar protease carboxypeptidase Y (CPY). In 
the absence of functioning Ssa in the cell (using a temperature sensitive ssa1-45 strain), CPY 
aggregated and displayed reduced degradation kinetics at the non-permissive temperature 
(101). Thus, these diverse functions of Ssa reflect its ability to interact with a variety of 
different substrates.  
The non-essential Ssb family is composed of two proteins, Ssb1 and Ssb2 that share 
99% identity and is fungal-specific. The expression of SSB1/2 is regulated similarly to 
ribosomal protein genes, supporting their role in cotranslational protein folding (74). The Ssb 
proteins are associated primarily with translating ribosomes and this interaction is not 
dependent on but is stabilized by the presence of a nascent polypeptide chain. As mentioned 
earlier, the Ssb proteins are associated with the ribosome through their interaction with the 
ribosome-associated complex (RAC) proteins (43). Although the binding site of Ssb on the 
ribosome has not been identified, it is predicted to be near the exit tunnel in close proximity 
to the nascent chain and RAC (108). Deletion of SSB1/2, ZUO1 or SSZ1 causes identical 
phenotypes including slow growth, cold sensitivity and hypersensitivity to translation- 
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TABLE 1-1. Hsp70 family of chaperones in S. cerevisiae 
 
 
 
 
Protein( Function(
( (Cytosol'
(Ssa1,(Ssa2( Constitutively(expressed,(protein(folding,(translocation(
Ssa3,(Ssa4( Stress(inducible,(protein(folding,(translocation(
Ssb1,(Ssb2( Ribosome@associated,(nascent(chain(folding(
Ssz1( Component(of(RAC,(nascent(chain(folding(through(Ssb(
( (ER'
(Kar2( Protein(folding,(translocation,(UPR(regulation(
( (Mitochondria'
(Ssc1( Protein(folding,(translocation(
Ssc3( Protein(folding,(translocation(
Ssq1( Folding(of(FeS(proteins(
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inhibiting drugs like hygromycin B and paramomycin. These shared phenotypes suggest both  
their involvement in translation and the formation of a functional triad in vivo (43, 60). The 
ATPase activity of Ssb proteins is stimulated only by Zuo1, which requires stable association 
with Ssz1 (75, 107). Ssz1 is different from other Hsp70s: it contains an unusually short SBD 
and lacks the α-helical lid subdomain. ATP binding and hydrolysis by Ssz1 is not required 
for its function in vivo, nor does it seem to interact with nascent polypeptides possibly due to 
its short SBD. 
J domain proteins of Hsp70 
 J proteins (also referred to as Hsp40 due to their apparent molecular mass) are 
homologous to DnaJ from E. coli and have the ability to accelerate the ATPase activity of 
Hsp70 (49). J protein structures contain a four-helix bundle approximately 70 amino acids in 
length and interact with Hsp70 through an invariable histidine-proline-aspartic acid (HPD) 
motif between helices II and III (148). Thirteen cytosolic J proteins have been identified in S. 
cerevisiae, of which Ydj1 is the best studied. Cells lacking YDJ1 are slow growing and 
stress-sensitive and the expression of other cytosolic J proteins can replace its function, 
suggesting a level of redundancy and functional overlap between these proteins.  
Hsp70 nucleotide exchange factors  
Nucleotide exchange factors (NEFs) are a group of structurally unrelated proteins that 
promote ADP release from the NBD of Hsp70, resetting the folding cycle for another round 
of ATP binding and hydrolysis (Figure 1-3). Much of the initial work on NEFs was done 
using E. coli NEF, GrpE with the E.coli Hsp70 homolog, DnaK. The steady-state (when ATP 
concentration >>> Hsp70 concentration) ATP turnover rate of unstimulated DnaK is very 
slow (between 0.02 and 0.2 min-1) to drive its chaperone function (99). For the DnaK 
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system, co-chaperones DnaJ and GrpE stimulate the ATP turnover rate several hundred-fold 
at saturating conditions (78). The crystal structure of a GrpE monomer reveals a long α-helix 
followed by a short α-helix and then a compact β-sheet domain at the C-terminus. The co-
crystal of GrpE shows that it binds as a dimer to an NBD of DnaK and provides the β-sheet 
domain at the cleft between the two lobes of the NBD, which causes domain IIB to move 
outward by 14°, resulting in nucleotide dissociation. 
Mge1, an essential mitochondrial matrix protein in S. cerevisiae shares 34% identity 
with E. coli GrpE and associates with mitochondrial matrix Hsp70s, Ssc1 and Ssq1 (72). The 
relative stoichiometry of the three proteins as determined by immunoprecipitation 
experiments, as the ratio of Ssc1 to Mge1 to Ssq1 is 250:50:1 (123). A conserved loop 
structure on the surface of the NBD of Ssc1 mediates its interaction with Mge1 and for 
Mge1-induced nucleotide exchange (84). Mge1 was shown to release both ADP and ATP 
from Ssc1, suggesting that the Mge1-binding interface of Ssc1 is similar in both the ATP- 
and ADP-bound forms, thus functioning as a nucleotide release factor for Ssc1. This NEF 
functions to modulate nucleotide-dependent stability of the Ssc1-Tim44 complex that is 
required for import of precursor proteins into the matrix. In addition, reduced rates of 
maturation of Yfh1, the yeast frataxin homolog required for iron homeostasis was seen in an 
mge1-100 temperature sensitive strain and in a strain lacking SSQ1, which suggests that 
Mge1 plays a role in posttranslocational folding with regard to Ssq1 function. Interestingly, 
the inactivation of Ssc1 in ssc1-3 mitochondria dramatically enhanced the interaction 
between Ssq1 and Mge1, suggesting a competitive interaction between the two Hsp70s for 
Mge1 association (123). The mitochondrial matrix thus provides a unique situation where the 
activity of two Hsp70 chaperones is governed by interactions with a single NEF.  
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In the early 2000s, three distinct families of NEFs were identified in the cytosol with both 
yeast and human/mammalian counterparts: the Hsp110s (Sse1/2), HspBP1 (Fes1) and BAG 
domain-containing proteins (Snl1).   
Hsp110 homologs in yeast, Sse1 and Sse2 are 76% identical to each other and are 
70% similar to Ssa1 with regard to amino acid sequence. Both Sse1 and Sse2 are expressed 
under normal conditions but Sse2 is 10 times less abundant than Sse1 (45). Deletion of SSE1 
results in a slow growth phenotype exacerbated by temperature stress, while loss of SSE2 is 
not associated with any phenotypic effects (89). Deletion of both genes is lethal, suggesting 
that both proteins comprise an essential gene product pair. The domain architecture of Sse1/2 
is similar to that of all Hsp70s with the exception of two extended spacer regions in the SBD 
but a number of unusual features of Sse proteins suggested that they might function 
differently than Hsp70s. Sse1 was found to bind but not hydrolyze ATP and Sse1 holds 
substrate proteins rather than fold them (130). Our lab and others showed that Sse proteins 
act as potent NEFs for Ssa and Ssb and that ATP binding by Sse1, but not the Hsp70 partner 
appears to be a requirement for their association (31, 115, 129). The crystal structure of Sse1 
revealed a domain architecture similar to Hsp70 but the α-helical lid subdomain of the SBD 
of Sse1 exists in an extended conformation that wraps around the distal face of Hsp70 to 
make additional contacts with lobe II of the Hsp70 NBD (125). The location of the Sse1 SBD 
in close proximity to the Hsp70 SBD suggests that both proteins may simultaneously bind 
certain substrates or Sse1 may recruit substrates followed by a “handoff” of the substrate to 
Hsp70. 
The Fes1 cochaperone was initially identified as the cytosolic homolog of the ER 
NEF Sil1 that interacts with the ER Hsp70 Kar2. Fes1 is also highly homologous to the 
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mammalian NEF HspBP1 (63, 65). Fes1 was shown to activate nucleotide exchange for Ssa 
and Ssb and will be discussed further in Chapter 5. 
The Bag-1 (Bcl-2-associated athanogene) protein was first identified as a binding 
partner of apoptosis inhibitor protein, Bcl-2 (144). It was later shown that a conserved 
domain comprising of about 100 amino acids at the carboxyl end of Bag-1 (BAG domain) 
directly interacts with the NBD of Hsc70 and stimulates its ATPase rate only in the presence 
of a J-protein, suggesting its role as an NEF. The crystal structure of the ~13 kDa BAG 
domain of Bag-1 in complex with the ATPase domain of Hsc70 shows a monomeric three 
helix bundle architecture with helices two and three making contacts with residues Met 61, 
Arg 261 and Glu 283 in subdomains IB and IIB of the ATPase domain (140). A structure-
based sequence alignment of the BAG domain of different species identified Snl1 as the sole 
BAG domain-containing protein in S. cerevisiae. In vitro studies show that Snl1 interacts 
with yeast Ssa and Ssb and mammalian Hsp70 and regulates the ATPase activity of Hsp70. 
In addition, two residues (E112, R141) that make contacts with the Hsp70 ATPase domain 
are absolutely conserved in BAG domain-containing proteins, and their disruption in Snl1 
affects its binding to Hsp70, confirming Snl1 as a bonafide BAG domain protein (139). Snl1, 
was shown to interact with Ssa and Ssb in vitro and its nucleotide exchange activity on 
Hsp70 was comparable with mammalian Bag-1 (139).  
Unlike mitochondria, which contain only one NEF, the ER of yeast and higher 
eukaryotes contains two NEFs, Sil1 and Lhs1 (Grp170 in mammals). Sil1 is a nonessential 
protein present in the ER lumen and interacts specifically with the NBD of Kar2/BiP, the ER-
resident Hsp70 (64, 149). SIL1 in yeast is synthetically lethal when disrupted in combination 
with mutant alleles of KAR2 and SEC63, suggesting that Sil1 plays a role in the translocation 
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of substrates into the ER. Sil1 stimulates Kar2 ATPase activity and preferentially binds to the 
ADP-bound conformation of Kar2 (64). Human Sil1 shares 20% sequence identity with yeast 
Sil1 and is suggested to represent a paralog of HspBP1, the Fes1 homolog in mammals (22). 
Deletion of SIL1 alone in yeast does not cause any effect but mutations in human Sil1 causes 
Marinesco-Sjogren syndrome characterized by cerebellar ataxia, cataracts and muscle 
weakness (127). The crystal structure of Sil1 in complex with NBD of BiP shows Sil1 to 
contain 16 α-helices (A1-A16) and no β-strands. The central helices A3-A14 form four 
Armadillo-like repeats (ARM1-ARM4). Each ARM is made of 3 α-helices that pack into a 
right-handed superhelix to produce a gently curved elongate molecule. Sil1 utilizes its 
concaved inner surface to embrace lobe IIB of the BiP NBD. Although Sil1 and HspBP1 
share limited sequence identity (13%) between them, they share a similar architecture with 
four central ARM repeats flanked by two amino- and carboxyl- terminal helices, suggesting 
evolutionary conservation of domain architecture (134, 164). LHS1 encodes a nonessential 
glycoprotein that shares 24% amino acid identity with Kar2. It is considered to be an 
“atypical” Hsp70 family member and is grouped with the Hsp110 family that cannot fold 
substrates in vivo. Lhs1 acts as an NEF for Kar2 and consistent with this evidence, it 
preferentially binds to the apo- and ADP-bound states of Kar2 (25). Lhs1 and Sse1 share key 
conserved Hsp70-binding residues and stimulate nucleotide exchange on their Hsp70 
partners using similar mechanisms (4). A key difference between Sse1 and Lhs1 is that Kar2 
reciprocally stimulates the ATPase activity of Lhs1. Similar to Sse1, Lhs1 and its 
mammalian homolog Grp170 were shown to also “hold” substrates, suggesting that 
“holdase” activity is a conserved function of this protein family (159). Since both Sil1 and 
Lhs1 bind Kar2, it was suggested that they do so in a mutually exclusive manner (143). The 
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combined deletion of LHS1 and SIL1 results in synthetic lethality and suggests a strict 
requirement of NEF activity for proper Hsp70 function in the ER (149).   
Aim of this work 
In yeast and human cells, the presence of multiple structurally distinct NEFs that 
perform the same biochemical function suggests that these NEFs may play distinct and/or 
overlapping roles as Hsp70 co-chaperones with respect to cellular processes, substrates and 
location in the cell. An ongoing research focus in the lab is to study the cellular roles of the 
three families of cytosolic NEFs. In this work, I will focus on two cytosolic NEFs, the unique 
ER membrane-associated Snl1 and free-floating Fes1. This investigation has provided novel 
insights into the roles that these proteins play in Hsp70-dependent cellular functions. 
Significance of this work 
 Molecular chaperones are an integral part of the proteostasis network and are vital 
components needed to maintain homeostasis of the cellular proteome. The proper assembly, 
processing and transport of cellular proteins requires the function of an ensemble of 
chaperones under normal and stressed conditions. Improper folding and defects in protein 
turnover can lead to a variety of diseases, described earlier in this chapter. Hsp70 is, by far, 
the most evolutionarily conserved protein within this group with many co-chaperones that 
can bind to it and regulate its substrate-folding cycle. Since the Hsp70 family of chaperones 
performs different tasks in the cell, regulation of its access to substrates is an important step. 
This regulatory activity is provided by co-chaperones that connect Hsp70 proteins with their 
target substrates and also with other chaperones like Hsp90. This occurs through a direct 
association with both the chaperone and the substrate (73). However, at the molecular level, 
it is not known how co-chaperones select their Hsp70 partners and substrates. In this study, 
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using primarily immunoprecipitation techniques, I identified a novel interaction between a 
cytosolic NEF of Hsp70 tethered to the ER and the ribosome, which might function to recruit 
Hsp70 to enhance folding at this cellular location. In addition, I discovered a binding 
specificity between another cytosolic NEF with one class of cytosolic Hsp70 present in yeast 
cells, suggesting its role in a substrate- or pathway-specific Hsp70 function. 
When I first began this study, very little was known about the binding partners of 
Snl1, an ER-localized cytosolic Hsp70 co-chaperone in yeast cells. A truncated variant of 
Snl1 that lacked the transmembrane domain was previously described to bind cytosolic 
Hsp70s, Ssa and Ssb in vitro and to facilitate the release of a bound nucleotide from Hsp70. 
Chapter 3 of the dissertation describes a novel interaction between full length or truncated 
Snl1 proteins and the ribosomal complex. Several lines of evidence indicate that this 
interaction is both independent of and concurrent with binding to Hsp70 and is not dependent 
on membrane localization. I further identify the ribosome-binding site on Snl1 and show that 
this interaction is conserved in the pathogenic fungus Candida albicans. To determine the 
intricacies of Snl1-Hsp70 interaction, in Chapter 4, I describe a preliminary analysis to find 
the minimal domains of Snl1 and CaSnl1 (C.albicans homolog) that bind Hsp70, and 
successfully developed a pilot purification strategy that will be used to allow structure 
determination by X-ray crystallography. This is part of an active collaboration and will be the 
first structures to be determined for Bag domain-containing proteins in fungi. 
In Chapter 5, I describe a preliminary follow-up of my original discovery of Fes1 to exhibit 
selectivity in binding cytosolic Hsp70s in yeast, as seen in Chapter 3. Previous in vitro data 
showed that Fes1 can bind both Ssa and Ssb but I found that Fes1 interacts specifically with 
Ssa. I showed that lack of Fes1 binding to Ssb is not due to its stoichiometric levels in the 
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cell. In addition, two proteins that associate with Ssb at the ribosome do not prevent Fes1 
from interacting with Ssb. This is the first evidence of an in vivo bias in binding of a 
cytosolic NEF with Hsp70. While Ssb is present on the ribosome and is involved in co-
translational protein folding, Ssa acts downstream to fold polypeptides post-translationally. 
This suggests that Fes1 functions at a later step in polypeptide folding and is recruited 
specifically for Ssa-dependent cellular functions. This observation demonstrates that 
although the three cytosolic NEFs have the same biochemical function, they may be utilized 
for distinct and/or overlapping cellular processes based on their abilities to bind cytosolic 
Hsp70s. Thus, targeting Hsp70 co-chaperone proteins to enhance or diminish the ability of 
the Hsp70 system to modulate substrate recognition, binding and release is an important area 
of research, especially with regard to protein aggregation diseases.  
 Taken together, the results presented in this dissertation establish novel binding 
partners for two distinct Hsp70 co-chaperones in yeast cells. These findings provide a basic 
framework for future studies into the importance of subcellular localization and binding 
specificities of Hsp70 co-chaperones in diverse cellular processes. 
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Chapter 2: Materials and Methods
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Strains and plasmids  
S. cerevisiae strains used in this study are listed in Table 2-1. The strains were grown 
in rich medium containing 1% yeast extract, 2% peptone and 2% dextrose (YPD). Synthetic 
complete (SC) medium lacking the appropriate nutrient for plasmid selection was purchased 
from Sunrise Science Products (San Diego,CA). Standard yeast propagation and 
transformation procedures were followed (66). Plasmids used in this work are listed in Table 
2-2. All plasmids were built using standard PCR and restriction enzyme cloning techniques.  
Polymerase chain reaction mutagenesis and recombination cloning 
 Site directed mutagenesis was performed via a PCR-based mutagenesis strategy and 
homologous recombination of PCR products. Plasmids were built by ordering 
complementary oligonucleotides containing identical changes in the region of interest. 
Overlap between PCR fragments and the vector backbone was no less than 40 base pairs. 
Correct plasmids were confirmed by restriction endonuclease analysis and by sequencing the 
inserts.  
pSnl1∆N-FLAG(E112A,R141A) was constructed in two steps using PCR-based 
recombination cloning. In brief, p413TEF was digested with Spe I and Xho I and used for 
gap repair via homologous recombination with pooled PCR products with the incorporated 
E112A substitution amplified from the template p413TEF-SNL1∆N-FLAG, with homology 
to the gapped plasmid ends (TEF2 promoter and CYC1 terminator). The second 
recombination round was performed with pooled PCR products with the incorporated R141A 
change amplified from the template p413TEF-SNL1∆N(E112A)-FLAG, with homology to 
the similar gapped plasmid ends. 
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Snl1 (5KA)-FLAG was constructed using recombination cloning. In brief, p413TEF 
was digested with Spe I and Xho I and used for gap repair via homologous recombination 
with pooled PCR products with the incorporated five lysine-to-alanine changes amplified 
from the template p413TEF-SNL1-FLAG, with homology to the gapped plasmid ends (TEF2 
promoter and CYC1 terminator). The construct p413TEF-SNL1-(5KA)-FLAG was used as 
the template to amplify SNL1∆N(5KA)-FLAG flanked by 5’ Spe I and 3’ Xho I sites for 
subsequent cloning into p413TEF. 
SNL1 and SNL1∆N (∆40) were amplified from BY4741 genomic DNA by use of 
standard PCR protocols and cloned into the vector p413TEF by use of 5’ Spe I and 3’ Xho I 
sites engineered into the amplifying oligonucleotide primers by use of standard DNA 
digestion and ligation protocols (90). In each case, a carboxyl-terminal FLAG 
(DYKDDDDK) epitope tag was also incorporated into the 3’-end primer sequence to 
facilitate immunoprecipitation of these proteins in the cell. The truncated alleles of SNL1 
(∆50, ∆60, ∆70, and ∆80) were amplified from p413TEF-SNL1∆NFLAG flanked by 5’ Spe I 
and 3’ Xho I sites for subsequent cloning into p413TEF.  
The hypothetical BAG domain-containing protein (ca19.997) from Candida albicans 
was amplified from SC5314 genomic DNA (kindly provided by the Lorenz Lab, Dept. of 
Microbiology and Molecular Genetics). A C-terminal FLAG tag and 5’ Spe I and 3’ Xho I 
sites were incorporated into the amplifying primer sequences for subsequent cloning into 
p413TEF. ca19.997 was C-terminally green fluorescent protein (GFP) tagged by using a 
method described previously (44). Briefly, PCR was performed by using the pGFPHIS1 
plasmid template with primers F1 and R2, and this product was transformed by 
electroporation into C. albicans strain SC5314. Transformants were selected by plating the 
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transformation mix onto histidine plates and verified by PCR.  
Plasmid pCDNA3/HA-Bag1 (141)(a gift from R. Morimoto, Northwestern 
University) was used as a template to amplify Mus musculus Bag-1 with a C-terminal FLAG 
tag and 5’ Spe I and 3’ Xho I sites that were incorporated into the amplifying primer 
sequences for subsequent cloning into plasmid p423GPD. 
Δ60SNL1 was amplified from BY4741 genomic DNA by use of standard PCR 
protocols and cloned into pPRoEX-HtB (Invitrogen, kindly provided by A.Bracher, Max 
Planck Institute for Biochemistry, Munich, Germany), by use of 5’ Spe I and 3’ Xho I sites 
engineered into the amplifying oligonucleotide primers by use of standard DNA digestion 
and ligation protocols. Δ103CaSNL1 was amplified from genomic DNA isolated from the C. 
albicans strain SC5314 by use of standard PCR protocols and cloned into pPRoEX-HtB 
(Invitrogen), by use of 5’ Spe I and 3’ Xho I sites engineered into the amplifying 
oligonucleotide primers by use of standard DNA digestion and ligation protocols. 
Yeast growth assays 
Plate growth assays were carried out by serial dilution using 1/10 dilution steps with a 
starting culture optical density at 600 nm of 1.0 and the resulting culture was transferred with 
a multipronged replicating tool from a 96-well plate.  
SDS-PAGE and Western blot analysis 
 Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) and transferred onto a polyvinylidene difluoride (PVDF) 
membrane (Millipore) for immunodetection. All antibodies were added in 5% solution of 
non-fat dry milk resuspended in TBST (0.684 M NaCl, 0.1 M Tris base [pH 7.6], 0.2% 
Tween-20). 
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Antibodies used in the study 
Antibody  Source Dilution 
Rabbit polyclonal Ssa1/2 
Dr. M.Ptashne (Sloan-Kettering 
Institute) 1:40,000 
Rabbit polyclonal Ssb1/2 Dr. E. Craig (University of Wisconsin) 1:5,000 
Rabbit polyclonal Rpl8  A. Johnson (University of Texas, Austin) 1:2,000 
Mouse polyclonal Rpl3  
J. Warner (Albert Einstein College of 
Medicine) 1:1,000 
Mouse monoclonal M2 
(FLAG)  Sigma Aldrich, St. Louis, MO 1:1,000 
Mouse monoclonal HA 
(12CA5) Roche Diagnostics, Indianapolis, IN 1:2,000 
 
Soluble protein extraction from yeast 
Cells expressing tagged proteins were harvested and resuspended in TEGN200 buffer 
(20mM Tris [pH7.9], 0.5 mM EDTA, 10% glycerol, 200 mM NaCl) containing protease 
inhibitors (2 µg/ml aprotinin, 2µg/ml pepstatin, 1µg/ml leupeptin, 1mM 
phenylmethylsulfonyl fluoride and 2µg/ml chymostatin [Sigma]), which we refer to as 
TEGN200+PI. Samples were lysed using acid-washed glass beads in a microtube mixer for 
five rounds of 1 min of lysis in each round followed by 1 min on ice. The lysate was cleared 
by centrifugation at 3,000 X g for 10 min at 4 °C. For KCl treatment, the lysate was split 
equally into four tubes containing 0,0.1,0.2 and 0.5 M KCl and incubated on ice for 30 min. 
For EDTA treatment, the Rps6B-3X hemagglutinin (3XHA) strain (10)(a gift from S. 
Baserga, Yale University) expressing Snl1∆N-FLAG was harvested and resuspended in 
TADM buffer (50 mM Tris [pH 7.5], 50 mM ammonium acetate, 1 mM dithiothreitol [DTT], 
5 mM magnesium chloride) with PI (TADM+PI) and lysed as described above. Snl1∆N was 
immunoprecipitated from the cell lysate, and the resin was washed two times with 
TADM+PI. The FLAG resin was split equally, 40 mM EDTA was added to one tube, and 
samples were incubated on ice for 30 min. The FLAG resin was washed two times, and the 
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proteins were eluted as mentioned below. 
In vivo FLAG immunoprecipitation 
 Soluble protein extracts were prepared from 25-100 ml of log-phase (A600=0.8) 
cultures of the appropriate strains. For immunoprecipitations (IPs), 30 µl of a 1:1 slurry of 
M2 resin (Sigma) in TEGN200 was added to the lysate. The volume was adjusted to 700 µl 
with TEGN200+PI, followed by incubation with mixing at 4°C for 2 h. Resin was then 
collected by centrifugation and washed seven times with TEGN+PI. For the elution of bound 
proteins, 35 µl of 200 µg/ml 2X-FLAG peptide (N-DYKDDDDKDYKDDDDK-
C)(GenScript) in TEGN200 was added to the resin pellet and incubated at room temperature 
for 15 min with occasional shaking. After incubation, the resin was pelleted by centrifugation 
at 3000 X g for 1 min at room temperature and the supernatant combined with an equal 
volume of 2X sample buffer (200 mM Tris-Cl (pH 6.8), 36% glycerol, 10% SDS, 5% β-
mercaptoethanol, 0.012% bromophenol blue). The resulting mixture was boiled for three 
minutes at 95 °C to denature protein complexes. To immunopurify membrane-bound Snl1, 
lysates were treated with 1% TritonX-100 to solubilize the protein before performing the 
immunoprecipitation reaction. 
Protein identification 
 Proteins were identified at the Proteomics Core Facility at the University of Texas 
Health Science Center at Houston. Tandem mass spectrometry (MS/MS) analysis was 
performed with an Applied Biosystems QStar Elite liquid chromatography-MS/MS (LC/MS/ 
MS) mass spectrometer equipped with an LC Packings high-performance liquid 
chromatography (HPLC) instrument for capillary chromatography. The HPLC instrument 
was coupled to the mass spectrometer by a Nanospray II electrospray ionization (ESI) source 
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for direct analysis of the eluate. For protein identification, proteins were separated on a 15% 
SDS-PAGE gel, stained using Coomassie brilliant blue and the gel was sent to the 
Proteomics Core Facility for band identification. 
In vitro protein-protein interaction assay 
Snl1∆N-FLAG was immunoprecipitated from strain BY4741 using anti-FLAG M2 affinity 
resin. For the competition assay, Snl1∆N bound to FLAG resin was combined with 
recombinant His6-Ssb (1 mg/ml), purified previously by Dr. Lance Shaner, a former member 
of the lab. The sample was incubated on ice for 30 min. Following incubation, the beads 
were reisolated and bound proteins were eluted as mentioned above. 
Pilot purification of His6-Δ60SNL1 and His6-Δ103CaSNL1 
Δ60Snl1 and Δ103CaSnl1 were expressed as N-terminally His-tagged fusion proteins using 
E. coli BL21 cells in Luria-Bertani (LB) broth supplemented with 100 µg/ml ampicillin 
(amp). Cells were sub-cultured into 50 ml LB + ampicillin at a 1:100 dilution and incubated 
at 37 °C. At two hours (OD600 of 0.6), 1mM IPTG was added to the cultures and grown 
subsequently for an additional three hours to induce protein expression. Cells were harvested 
by centrifugation at 8,000 rpm for 20 minutes at 4 °C. The cell mass from a 50 ml culture 
was resuspended in 5 ml of buffer B (50 mM Tris-HCl (pH 7.6), 5 mM Imidazole, 2 mM 
MgCl2, 200 mM NaCl) containing protease inhibitors (P.I.)(aprotinin 2 µg/ml; pepstatin A, 2 
µg/ml; leupeptin, 1 µg/ml; phenylmethylsulfonyl fluoride, 1 mM; chymostatin, 2 µg/ml; 
Sigma). Cell lysis via French Press was performed for two rounds of 1000 psi each. After 
removal of the cell debris by centrifugation at 8,000 rpm for 20 min, the lysate (approx.. 4 
ml) was added to a pre-chilled 15 ml centrifuge tube containing 500 µl (1:1slurry) of Ni-
NTA (Qiagen), pre-equilibrated using buffer B. The volume was brought to 10 ml to enable 
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efficient mixing. Samples were incubated for three hours at 4 °C with gentle mixing. Each 
sample was then loaded onto a Polyprep chromatography column and the flow-through (FT) 
was collected by gravity flow after the resin was allowed to settle. The resin was washed 
once with 5 ml buffer B (W1) followed by 5 ml buffer B containing 500 mM NaCl (buffer 
B500)(W2). The final wash step was done using 5 ml buffer B500 containing 50 mM 
imidazole (W3). Bound proteins were eluted in two steps; first with 2 ml Buffer B500 
containing 200 mM imidazole (E1) and second by 2 mL Buffer B500 supplemented with 500 
mM imidazole (E2). The protein content of each fraction was analyzed on a 15% SDS-PAGE 
gel.  
Microscopy  
 Candida albicans cells were harvested by centrifugation, washed once with water, 
and resuspended in 70% ethanol for fixation for 1 min. Cells were once again harvested by 
centrifugation and resuspended in water for visualization. Nuclei of living cells were stained 
with the vital DNA dye Hoechst 33342 at a concentration of 10 g/ml for 5 min. Cells were 
observed under a BX60 epifluorescence microscope (Olympus, Tokyo, Japan) equipped with 
a 100X immersion oil objective and 4’,6-diamidino-2-phenylindole or GFP filter cubes. 
Images were captured with a Photometrics CoolSNAP-fx cooled charge-coupled-device 
camera driven by QED image-capturing software (Media Cybernetics, Bethesda, MD). All 
images were processed by using Photoshop CS (Adobe Systems, San Jose, CA). 
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TABLE 2-1. LIST OF STRAINS USED IN THIS STUDY 
 
Strain Name Genotype Source or 
Reference 
BY4741 MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 
Open Biosystems 
snl1Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 snl1::KanMX 
Open Biosystems 
sse1Δ 
 
ssz1Δ 
MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 sse1::KanMX 
MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 ssz1::KanMX 
Open Biosystems 
 
Open Biosystems 
zuo1Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 zuo1::KanMX 
Open Biosystems 
egd1Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 egd1::KanMX 
Open Biosystems 
egd2Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 egd2::KanMX 
Open Biosystems 
btt1Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 btt1::KanMX 
Open Biosystems 
sbh1Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 sbh1::KanMX 
Open Biosystems 
sbh2Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 sbh2::KanMX 
Open Biosystems 
ssh1Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 ssh1::KanMX 
Open Biosystems 
sec66Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 sec66::KanMX 
Open Biosystems 
sec72Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 sec72::KanMX 
Open Biosystems 
nat4Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 nat4::KanMX 
Open Biosystems 
nup188Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 nup188::KanMX 
Open Biosystems 
ubr1Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 ubr1::KanMX 
Open Biosystems 
ssz1Δsnl1Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 ssz1::KanMX snl1::LEU2 
This study 
zuo1Δsnl1Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 zuo1::KanMX snl1::LEU2 
This study 
egd1Δsnl1Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 egd1::KanMX snl1::LEU2 
This study 
egd2Δsnl1Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 egd2::KanMX snl1::LEU2 
This study 
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btt1Δsnl1Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 btt1::KanMX snl1::LEU2 
This study 
sbh1Δsnl1Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 sbh1::KanMX snl1::LEU2 
This study 
sbh2Δsnl1Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 sbh2::KanMX snl1::LEU2 
This study 
ssh1Δsnl1Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 ssh1::KanMX snl1::LEU2 
This study 
sec66Δsnl1Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 sec66::KanMX snl1::LEU2 
This study 
sec72Δsnl1Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 sec72::KanMX snl1::LEU2 
This study 
nat4Δsnl1Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 nat4::KanMX snl1::LEU2 
This study 
nup188Δsnl1Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 nup188::KanMX snl1::LEU2 
This study 
ubr1Δsnl1Δ MATa his3Δ1/ leu2Δ0/ met15Δ0/ 
ura3Δ0 ubr1::KanMX snl1::LEU2 
This study 
DS10 MATa leu2-3,112 trp1-1 ura3-52 lys1 
lys2 his3-11,15 
 
(96) 
ssb1Δssb2Δ MATa Δssb1::HIS3 Δssb2::LEU2 leu2-
3,112 trp1-1 ura3-52 lys1 lys2 his3-
11,15 
(94) 
rps6b-3xHA MATa ura3-52 lys2-80 ade2-101trp1-
Δ63 his3-Δ200 leu2-Δ1 
 
(10) 
RSY1293 (sec61-
wt) 
MATa can 1-100 leu2-3,-112 his3-11,-
15 trp1-1 ura3-1 ade2-1 sec61::HIS3 
[pDQ1] 
(109) 
RSY1295 (sec61-
mutts) 
as RSY1293 except [psec61-41] (109) 
SC5314 C. albicans prototrophic wild type 
strain 
(39) 
SC5314 
SNL1::GFP 
(CaSnl1) 
orf19.997/orf19.997-GFP::HIS1 This study 
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TABLE 2-2. LIST OF PLASMIDS USED IN THIS STUDY 
 
Plasmid Description 
p413TEF-FLAG-SSE1 
 p413TEF-FLAG-SSE2 
 p413TEF-FLAG-FES1 
 p413TEF-SNL1-FLAG 
 p413TEF-SNL1ΔN-FLAG lacks first 40 residues 
p413TEF-SNL1ΔN**-FLAG SNL1 mutant,(E112A,R141A),lacks first 40 residues 
p413TEF-SNL1Δ50-FLAG lacks first 50 residues 
p413TEF-SNL1Δ60-FLAG lacks first 60 residues 
p413TEF-SNL1Δ70-FLAG lacks first 70 residues 
p413TEF-SNL1Δ80-FLAG lacks first 80 residues 
p413TEF-SNL1ΔN(5KA)-FLAG 5-Lys to Ala change between residues 52-58 
p413TEF-CaSNL1Δ91-FLAG Candida albicans SNL1,lacks first 91 residues 
p413TEF-CaSNL1Δ103-FLAG Candida albicans SNL1,lacks first 103 residues 
pGFPHIS1 
contains GFP cassette for PCR-mediated gene tagging 
in Candida albicans 
pCDNA3/HA-Bag1 Contains 30 kDa small Bag-1 isoform 
pPROEX-HtB-Δ60SNL1 
N-terminally tagged His6-tagged SNL1,lacks first 60 
residues 
pPROEX-HtB-Δ103CaSNL1 
N-terminally tagged His6-tagged Candida albicans 
SNL1,lacks first 103 residues 
p423GPD-FLAG-FES1 high copy vector 
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Chapter 3: SNL1 encodes a novel ribosome associated 
nucleotide exchange factor in fungi 
 
 
 
 
 
 
 
NOTE: This chapter is derived from work that has been published in 2012: “A lysine-rich region within fungal 
BAG domain-containing proteins mediates a novel association with ribosomes.” “Copyright © American 
Society for Microbiology, Eukaryotic Cell 2012, 11(8):1003. DOI: 10.1128/EC.00146-12. I am the primary 
author on this paper and was responsible for preparing the original manuscript. I performed all experiments 
described in this chapter. As an author, I have been granted permission by the publisher of Eukaryotic Cell, the 
American Society for Microbiology, to reproduce any/all of my manuscript in print or electronically for the 
purpose of my dissertation. 
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3A. INTRODUCTION 
 SNL1 was initially identified in a genetic multicopy suppressor screen for lethality 
caused by the expression of a truncated mutant allele of the nuclear pore protein Nup116 
linking the function of Snl1 to nuclear pore assembly and function (54). Although a direct 
role for Snl1 in nuclear transport is unclear, the different phenotypes seen here suggest that 
Snl1 might provide a localized stimulation of Hsp70 in folding certain partially misfolded 
proteins associated with the nuclear pore complex. However, little else is known about the 
cellular roles of Snl1. Snl1 is unique among all known Hsp70 NEFs in containing an amino-
terminal transmembrane region that tethers it to the ER membrane, with the BAG 
domain/Hsp70-binding domain facing the cytosol (139). Unlike the phenotypes seen with the 
loss of SSE1 or FES1 in yeast cells, snl1Δ cells show no observable phenotype.  
The goal of this project was to identify cellular binding partners of full length Snl1 
and a truncated variant lacking the amino-terminal transmembrane domain and to determine 
the function of Snl1 as an Hsp70 co-chaperone at the ER membrane. In this study, I report 
the novel interaction of Snl1 with the ribosome complex, in addition to its association with 
Hsp70. I have biochemically characterized this ternary complex and show that Snl1 binds 
predominantly to the 60S subunit, independent of Hsp70 binding and suggest the presence of 
two separate interaction surfaces on Snl1. I show that this is a conserved interaction in 
Candida BAG domain-containing proteins using the sole Snl1 homolog in the pathogenic 
fungus, Candida albicans. The ribosome binding interface in these proteins contains a lysine-
rich region and is situated in the putative helix one region of the BAG domain (152).  
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3B. RESULTS 
Snl1 is associated with intact ribosomes 
 Previous in vitro results had shown that the cytosolic BAG domain homology region 
of Snl1 interacts with the yeast cytosolic Hsp70s Ssa and Ssb (139). This interaction is 
consistent with the mammalian BAG domain protein, Bag-1, which interacts directly with the 
N-terminal NBD of Hsc70 (Figure 3-1) (140). However, whether Snl1 interacts with the 
cytosolic Hsp70s in vivo was unknown. To test this, I constructed expression vectors to 
produce FLAG-tagged full length Snl1 (FL-Snl1) and a truncated variant of Snl1 (Snl1∆N) 
that lacks the N-terminal transmembrane domain but contains the entire cytosolic region 
starting at residue 40 and includes the conserved BAG domain. I affinity purified both 
proteins using M2-agarose resin from cell lysates, which were solubilized with 1% TritonX-
100 to release membrane-bound Snl1. In addition to these two Snl1 proteins, I independently 
expressed FLAG-tagged Sse1, Sse2 and Fes1 fusions from the identical promoter to compare 
Hsp70 purification patterns. In addition to Ssa and Ssb, Snl1 and Snl1∆N copurified at least 
20 additional bands (Figure 3-2). In contrast, these proteins were absent when the three other 
FLAG-tagged NEFs were isolated, while Ssa and Ssb were identified in all the pulldowns. I 
noticed that the amount of Ssa that copurified with the two Snl1 proteins was 
disproportionately reduced relative to the amounts of the other three NEFs. In addition, 
FLAG-Fes1 appeared to associate specifically with Ssa in vivo, with little to no Ssb 
copurifying with it. This observation will be discussed further in Chapter 5. To identify 
individual Snl1-copurifying bands, mass spectrometry was used. This analysis assigned all 
the bands as large (L) and small (S) ribosomal subunit proteins (Figure 3-2) (Table 3-1). To 
compare this novel interaction and to identify whether substoichiometric amounts of 
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ribosomes might be copurifying with the other NEFs, I performed a Western blot using Rpl8, 
a large subunit ribosomal protein. This verified that the interaction with the ribosome was 
specific to FL-Snl1 and Snl1∆N and no interaction was detected with the other NEFs. This is 
the first report of an interaction between a BAG domain-containing protein and the 
assembled 80S ribosome. These results also indicate that ribosome binding by Snl1 is 
independent of its attachment to the ER/nuclear membrane.  
Differential binding patterns of Snl1 
 The ribosome-associated Hsp70, Ssb has been shown to continue associating with 
ribosomes after a high-salt wash procedure (1 M KCl), suggestive of a tight protein-protein 
interaction. I sought to determine if Snl1∆N was an integral part of the ribosome complex or 
a peripheral ribosome-associated protein by subjecting Snl1∆N-ribosome complexes to 
various concentrations of KCl before performing the immunoprecipitation using M2 resin. I 
observed an association of Snl1∆N with Hsp70 at all KCl concentrations tested (Figure 3-3). 
In contrast, the interaction of Sn1∆N with the ribosome was drastically reduced at KCl 
concentrations above 0.2 M. Ribosome binding was confirmed by an immunoblot for Rpl3, 
another large-subunit ribosomal protein. These results show that Snl1∆N is peripherally 
associated with ribosomes and suggest that the Snl1∆N-ribosome interaction is independent 
of the previously described Snl1∆N-Hsp70 binding.  
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FIGURE 3-1. Structure of the BAG domain of Bag-1 with Hsc70 NBD. Co-crystal 
structure of the BAG domain of human Bag-1 with bovine Hsc70 ATPase domain (NBD) 
reveals a three-helix bundle where helices 2 and 3 contact Hsc70. The two lobes of the NBD 
are sub-divided into IA/IB and IIA/IIB. PDB ID:1HX1. (140) 
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FIGURE 3-1. Structure of the BAG domain of Bag-1 with Hsc70 NBD   
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FIGURE 3-2. Snl1 interacts with ribosomal proteins. Amino- or carboxyl-terminally 
FLAG (F)-tagged NEFs were immunoprecipitated from wild type (BY4741) whole-cell 
lysates. Immunoblot analysis was used to detect interacting proteins using anti-Ssa, anti-Ssb 
and anti-Rpl8 antisera. Red letters represent ribosomal proteins of the large (L) and small (S) 
subunit that were identified by using mass spectrometry. EV, empty vector; CBB, Coomassie 
brilliant blue; IP, FLAG immunoprecipitation; IB, immunoblot of the whole-cell lysate. 
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FIGURE 3-2. Snl1 interacts with ribosomal proteins 
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TABLE 3-1. List of Snl1-binding proteins 
 
Protein 
Score 
S. cerevisiae 
Accession # 
Protein 
mass Protein description  
 149 RL3_YEAST 43730 60S ribosomal protein L3 
 163 RL4A_YEAST 39068 60S ribosomal protein L4-A 
 183 RL8B_YEAST 28151 60S ribosomal protein L8-B 
 329 RL7A_YEAST 27621 60S ribosomal protein L7-A  
 159 RPL2_YEAST 27392 60S ribosomal protein L2 
 181 RS6_YEAST 27037 40S ribosomal protein S6  
 94 RS3_YEAST 26543 40S ribosomal protein S3  
 270 RS5_YEAST 25080 40S ribosomal protein S5  
 149 RL1_YEAST 24698 60S ribosomal protein L1  
 44 RL15A_YEAST 24464 60S ribosomal protein L15-A  
 57 RL13A_YEAST 22540 60S ribosomal protein L13-A  
 169 RS9A_YEAST 22429 40S ribosomal protein S9-A  
 205 RL16B_YEAST 22235 60S ribosomal protein L16-B  
 197 RL16A_YEAST 22187 60S ribosomal protein L16-A  
 60 RS7B_YEAST 21621 40S ribosomal protein S7-B  
 398 RL9A_YEAST 21613 60S ribosomal protein L9-A  
 176 RS7A_YEAST 21609 40S ribosomal protein S7-A  
 180 RL18_YEAST 20608 60S ribosomal protein L18  
 36 RL17A_YEAST 20537 60S ribosomal protein L17-A  
 120 RL20_YEAST 20424 60S ribosomal protein L20  
 192 RL6A_YEAST 19949 60S ribosomal protein L6-A  
 172 RL11A_YEAST 19764 60S ribosomal protein L11-A  
 159 RL21A_YEAST 18288 60S ribosomal protein L21-A  
 202 RL12_YEAST 17869 60S ribosomal protein L12  
 96 RL24A_YEAST 17603 60S ribosomal protein L24-A  
 70 RS18_YEAST 17084 60S ribosomal protein S18 
 271 RS13_YEAST 17018 40S ribosomal protein S13  
 25 RL28_YEAST 16712 60S ribosomal protein L28  
 25 RL28_YEAST 16712 60S ribosomal protein L28  
 223 RL28_YEAST 16712 60S ribosomal protein L28  
 124 RL25_YEAST 15748 60S ribosomal protein L25  
 102 RS20_YEAST 13899 40S ribosomal protein S20  
 48 RL34A_YEAST 13859 60S ribosomal protein L34-A  
 70 RS26A_YEAST 13724 40S ribosomal protein S26-A  
  
Proteins reported at <0.05 significance 
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FIGURE 3-3. Snl1ΔN interaction with ribosomal proteins is salt sensitive. Whole-cell 
lysate from wild-type BY4741 expressing Snl1ΔN-FLAG was split equally and incubated on 
ice for 15 min with the indicated concentrations of KCl. Snl1ΔN was immunoprecipitated, 
and interacting proteins were separated on a 15% SDS-PAGE gel. Rpl3 and Snl1ΔN (anti-
FLAG antibody) were detected by immunoblot analysis. Distinct large subunit ribosomal 
proteins are indicated. CBB, Coomassie brilliant blue; IP, FLAG immunoprecipitation; IB, 
immunoblot of the whole-cell lysate. 
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FIGURE 3-3. Snl1ΔN interaction with ribosomal proteins is salt sensitive  
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Interaction of Snl1 with the ribosome is Hsp70 independent 
 It has been previously shown that the cytosolic Hsp70, Ssb is associated with 
ribosomes (108). Because my results show Snl1 to also associate with Ssb, I sought to 
determine whether ribosome copurification with Snl1 was dependent on Ssb. Since Ssb1 and 
Ssb2 are not essential, I first determined whether the Snl1∆N-ribosome interactions occurred 
in a strain that lacks these two Hsp70 genes. Snl1∆N-FLAG was expressed and isolated from 
a wild type and ssb1∆ssb2∆ strain. As shown in (Figure 3-4,A), I found that Snl1 remained 
associated with the ribosome complex in the ssb1∆ssb2∆ strain and the interaction was 
verified by immunoblotting for Rpl3. 
 To confirm this result, I took a parallel approach and took advantage of mutation 
shown previously to drastically reduce binding to Ssa and Ssb by constructing a FLAG-
tagged allele of SNL1 containing alanine substitutions at two residues critical for Hsp70 
interaction (Snl1∆N-FE112A, R141A) (139). To determine if Snl1∆N interacted with the 
ribosome in the absence of Hsp70 binding, I immunoprecipitated the mutant variant and the 
isogenic wild type as a control. In line with previous findings, this mutant exhibited 
considerably reduced binding to both Ssa and Ssb in vivo, as shown by the respective 
immunoblots (Figure 3-4,B). In contrast, binding to ribosomes, as assessed by an anti-Rpl3 
immunoblot was unaffected. Taken together, these two independent approaches show that 
Hsp70 does not mediate the association of Snl1∆N with the ribosome.  
The ribosome and Hsp70 exhibit non-competitive binding to Snl1 
 The data presented above shows that Snl1 is associated with ribosomes and this 
association does not require Hsp70. However, this does not establish whether this binding 
occurs in a novel or shared binding interface on Snl1. To investigate this question, I 
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FIGURE 3-4. Snl1ΔN interacts with the ribosome independently of Hsp70. (A) Whole-
cell lysates from a ssb1Δssb2Δ strain (Δ) or its isogenic wild-type (WT) (DS10) strain 
expressing either the empty vector (EV) or Snl1ΔN were subjected to FLAG 
immunoprecipitation (IP). Stably produced proteins were detected with anti-Ssb, anti-Rpl3 
and anti-FLAG antisera. (B) FLAG-tagged Snl1ΔN, either wild-type or E112A,R141A 
mutant, was immunoprecipitated from wild-type (BY4741) cells. Immunoblot analysis was 
used to detect stably produced protein with anti-Ssa, anti-Ssb, anti-Rpl3 and anti-FLAG 
antisera. IB, immunoblot of the whole-cell lysate. 
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FIGURE 3-4. Snl1ΔN interacts with the ribosome independently of Hsp70  
  
A 
B 
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performed a competitive binding experiment using purified Hsp70, Ssb (Figure 3-5,A). 
Snl1∆N-ribosome-Hsp70 complexes were first isolated by using M2 resin as described 
previously. This complex was mixed with 1 mg/ml recombinant His6-Ssb or buffer alone and 
then washed and reisolated prior to recovery by elution. (Figure 3-5,B) shows that Snl1∆N 
immunoprecipitated from cell extracts copurified with endogenous Ssb and the ribosome. On 
the addition of exogenous His6-Ssb, the binding of endogenous Ssb to Snl1∆N was 
outcompeted, as expected and seen by the slower migration likely caused by the His6 tag. 
Interestingly, the interaction with the ribosome remained intact. This finding suggests that 
Hsp70 and the ribosome interact with Snl1 in a noncompetitive manner, consistent with the 
presence of two distinct and independent binding sites on Snl1. 
Snl1 binds to the 60S ribosomal subunit 
 Mass spectrometric analysis of the multiple bands that copurified with Snl1 and 
Snl1∆N showed the presence of protein components of both the large and small ribosomal 
subunits. To determine which subunit might be interacting directly with Snl1, I treated the 
Snl1∆N-ribosome-Hsp70 copurified complex with EDTA. EDTA treatment is a well-
characterized method used to separate the two subunits of the ribosome by chelating the 
Mg2+ ions required for the 60S-40S subunit assembly. Snl1∆N-FLAG was expressed in and 
immunoprecipitated from a yeast strain containing a chromosomally epitope-tagged small 
subunit of the ribosome (Rps6B-3XHA), which allowed for the detection of the 40S 
component. Protein complexes were incubated in the absence or presence of 40 mM EDTA 
and washed to remove unbound proteins. Bound proteins were then eluted. I found a 
dramatic decrease in the amount of the 40S subunit co-eluting with Snl1∆N-FLAG, with very 
little change in the binding capacity of Snl1∆N with Rpl8 (Figure 3-6). This result can 
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FIGURE 3-5. The ribosome and Hsp70 exhibit non-competitive binding to Snl1ΔN. (A) 
Schematic of binding between Snl1 with either the ribosome and/or Hsp70. If the binding of 
Hsp70 and ribosome with Snl1 is competitive, addition of exogenous Ssb (pink with H6 
attached) will titrate Snl1 away from the ribosome. (upper arrow). Non-competitive binding 
will result in continued binding between Snl1 and the ribosome when exogenous Ssb is 
added. (lower arrow). (B) Snl1ΔN-FLAG expressed in BY4741 cells was immobilized onto 
M2 FLAG resin and incubated with His6-Ssb (1 mg/ml) for 30 min on ice, followed by 
another round of immunoprecipitation. Bound proteins were eluted as described in Materials 
and Methods, and immunoblot analysis was performed to detect interacting proteins with 
anti-Rpl3 and anti-FLAG antisera. The Ssb antibody detected endogenous (bottom band) and 
recombinant (bottom band) Ssb present in the fractions. 
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FIGURE 3-5. The ribosome and Hsp70 exhibit non-competitive binding to Snl1ΔN  
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be interpreted to indicate that Snl1 predominantly binds to the large (60S) ribosomal subunit.  
Identification of the ribosome binding site in Snl1 
 Results from the competitive binding experiment demonstrated that the ribosome 
binding site within Snl1 was distinct from its Hsp70 binding site. Based on the known BAG 
domain structure of protein Bag-1, the majority of Hsp70 contacts are localized to helices 2 
and 3. Because my data suggest that Snl1 can concomitantly bind both Hsp70 and the 
ribosome, steric hindrance would likely prevent both binding sites being located within these 
two helices. To identify the ribosome binding site in Snl1, I constructed a series of amino- 
terminal truncation mutants by sequentially deleting 10 residues starting at the beginning of 
putative helix 1 of Snl1 (Figure 3-7,A). All constructs were individually expressed in yeast 
cells and FLAG immunoprecipitated as described in Materials and Methods. With the 
exception of the ∆80 mutant, all the truncation mutant proteins were stably expressed. In 
addition, all these proteins except ∆80 mutant retained binding to Ssa and Ssb, as determined 
by Coomassie-dye staining, suggesting that they were all properly folded (Figure 3-7,B). 
Strikingly, I noticed that the ribosome interaction was lost in the ∆60 and ∆70 truncation 
mutants, as indicated by Coomassie-dye staining and the immunoblot for Rpl3. These results 
suggested that residues required for ribosome binding were found between residues 50 and 
60. An evaluation of the amino acids in this region revealed a concentration of five lysine 
residues (residues 52 to 58), which would be expected to provide a positively charged 
binding interface, not uncommon in ribosome binding proteins (Figure 3-7,A). To directly 
determine if this region was indeed responsible for ribosome binding, I constructed a mutant 
of Snl1∆N in which the five lysine residues were replaced with an uncharged residue, 
alanine, which I have named Snl1∆N (5KA). I separately immunoprecipitated this mutant 
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FIGURE 3-6. Snl1ΔN binds to the 60S ribosomal subunit. Snl1ΔN-FLAG expressed in an 
Rps6B-3XHA strain was immobilized on M2 FLAG resin. The resin was equally split and 
treated with and without 40 mM EDTA for 30 min on ice to dissociate intact ribosomes. 
Bound proteins were eluted as described in Materials and Methods, and immunoblot analysis 
was performed to detect proteins with anti-HA, anti-Rpl8, and anti-FLAG antisera. 
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FIGURE 3-6. Snl1ΔN binds to the 60S ribosomal subunit  
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FIGURE 3-7. Identification of the ribosome-binding site in Snl1. (A) N-terminal 
truncations within putative helix 1 of the Snl1 BAG domain are depicted. The lysine-rich 
region between resides 50 and 60 in Snl1 are highlighted, and the residue changes are 
indicated. TM, putative transmembrane domain. (B) FLAG (F)-tagged Snl1ΔN truncations 
were immunoprecipitated from the wild-type (BY4741) whole-cell lysate. Immunoblot 
analysis was used to detect ribosomal proteins with anti-Rpl3 antisera. CBB, Coomassie 
brilliant blue; IP, FLAG immunoprecipitation; IB, immunoblot of the whole-cell lysate. 
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FIGURE 3-7. Identification of the ribosome-binding site in Snl1   
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and Snl1∆N from yeast cell extracts to assess ribosome association. As seen by Coomassie-
dye staining and by immunoblotting, the 5KA mutant exhibited a drastic reduction in 
ribosome binding (Figure 3-8). In contrast, the interactions with Ssa and Ssb remained 
unchanged. These results demonstrate that this positively charged region within Snl1 is 
specifically required for ribosome association but not Hsp70 binding.  
Conservation of ribosome association in a fungal Bag-1 homolog 
 The identification of a specific sequence within Snl1 required for ribosome binding 
prompted me to ask whether this was a conserved or unique feature of Bag-1 homologs. As 
shown in (Figure 3-9), putative Bag-1 homologs could be identified in a range of eukaryotic 
organisms, many of which possess positively charged regions in the amino terminus of the 
predicted BAG domain. Interestingly, the genome of the human pathogenic fungus Candida 
albicans encodes a single predicted protein (orf19.997) that bears a high level of sequence 
conservation (32% identity and 59% similarity) with Snl1. This predicted protein also 
contains a putative N-terminal transmembrane region and a domain homologous to the BAG 
domain with a lysine-rich region in putative helix 1 (Figure 3-10,A). This is in contrast to the 
small isoform of the mammalian Bag-1 protein (Bag-1S), which, despite significant sequence 
homology (25% identity), lacks both a transmembrane domain and a lysine-rich region. This 
led me to speculate that the C. albicans Snl1 (CaSnl1) homolog (i) would localize to the ER 
and (ii) would associate with ribosomes. The next two experiments were performed to test 
these two predictions.  
To test if CaSnl1 associates with ribosomes, I generated two truncated forms of CaSnl1 from 
C. albicans strain SC5314 and expressed them in S. cerevisiae cells. CaSnl1∆91 lacks the 
first 90 amino acids of the proteins including the predicted transmembrane domain but 
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FIGURE 3-8. Snl1ΔN interacts with the ribosome via a lysine-rich region. FLAG-tagged 
Snl1ΔN, either the wild type (WT) or the 5KA mutant, where five lysine residues between 
residues 50 and 60 were changed to alanine, was immunoprecipitated from wild-type 
BY4741 cells, and immunoblot analysis was used to detect stably produced proteins with 
anti-Rpl3 antisera. IP, FLAG immunoprecipitation; IB, immunoblot of the whole-cell lysate. 
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FIGURE 3-8. Snl1ΔN interacts with the ribosome via a lysine-rich region   
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contains the lysine-rich region. CaSnl1∆103 lacks both regions (Figure 3-10,A). A murine 
Bag-1 cDNA was also expressed in yeast to determine whether the absence of the lysine-rich 
region in a distinct Bag-1 homolog would preclude ribosome interactions. I observed that 
CaSnl1 exhibited the same characteristics for ribosome binding as Snl1, with both variants 
binding Hsp70 but only the ∆91 construct binding ribosomes (Figure 3-10,C). In addition, 
murine Bag-1 associated with Hsp70 demonstrating the high level of conservation within the 
Hsp70 binding domain, but failed to interact with yeast ribosomes. These experiments 
demonstrate that a lysine-rich region within putative helix 1 of the BAG domain mediates 
interactions with the assembled ribosomes in two closely related fungi, whereas this 
interaction is not conserved in Bag-1S in mammalian cells.  
To test the prediction that CaSnl1 would localize to the ER, I carboxy-terminally 
tagged one copy of the gene in C. albicans with GFP using a previously described method 
(44). Due to the limited availability of fluorescent organellar localization markers in this 
organism, I stained live cell nuclei with the DNA-intercalating Hoechst dye to identify the 
nucleus. Untagged control cell exhibited discrete nuclear staining, with no background signal 
in the green channel. In contrast, CaSnl1-GFP was clearly seen to localize around the nucleus 
and at the cell periphery, consistent with known perinuclear and cortical ER localization 
patterns and with previous reports of the localization of Snl1 in S. cerevisiae (Figure 3-10,B).  
Synergistic growth assay between snl1∆ and strains lacking ribosome-associated 
chaperones 
 Because no detectable phenotype has been assigned to snl1∆ cells, I sought to 
determine if the loss of SNL1 would have a synthetic growth defect in strains that lacked 
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FIGURE 3-9. Cartoon sequence alignment of BAG domain-containing proteins in select 
organisms. Mm; Mus musculus, Sp; Schizosaccharomyces pombe, Ca; Candida albicans, Sc; 
Saccharomyces cerevisiae. Putative transmembrane regions (TM) are shown. Putative 
positively charged-rich ribosome binding residues are shown in the boxes. Numbers 
represent the amino acid length of each protein. 
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FIGURE 3-9. Cartoon sequence alignment of BAG domain-containing proteins in select 
organisms. 
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FIGURE 3-10. Ribosome association is conserved in the only BAG domain-containing 
protein of Candida albicans. (A) Illustration of the sequence alignment of BAG domain-
containing proteins of Saccharomyces cerevisiae (Sc Snl1) and Candida albicans (Ca Snl1) 
showing the lysine-rich region at the amino terminus of putative helix 1 and the predicted 
transmembrane (TM) domains. Murine Bag-1 (Mm BAG-1) lacks both a TM domain and a 
lysine-rich region. Mm, Mus musculus. (B) Localization of the chromosomally tagged C. 
albicans Snl1 homolog (CaSnl1-GFP) in wild-type C. albicans strain SC5314 was 
determined by fluorescence microscopy. Cells were stained with Hoechst 33342 dye to 
facilitate the assessment of perinuclear ER localization. (C) Snl1ΔN-FLAG from S. 
cerevisiae and the corresponding truncations in the C. albicans Snl1 homolog and the 
mammalian Bag-1 protein were expressed and immunoprecipitated from the wild-type 
(BY4741) yeast whole-cell lysate. Proteins were separated on a 15% SDS-PAGE gel, and 
immunoblot analysis was used to detect ribosomal proteins with anti-Rpl8 antisera. CBB, 
Coomassie brilliant blue; IP, FLAG immunoprecipitation; IB, immunoblot of the whole-cell 
lysate. 
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FIGURE 3-10. Ribosome association is conserved in the only BAG domain-containing 
protein of Candida albicans.  
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known ribosome associated chaperones. Deletion of SNL1 in combination with the two 
proteins that comprise the ribosome associated complex (RAC), SSZ1 and ZUO1 caused no 
detectable growth impairment at normal temperature and heat stress of 39 °C (Figure 3-
11,A).  
 Deletion of SNL1 from strains lacking individual genes of the nascent chain 
associated complex (NAC), EGD1, BTT1 and EGD2 also caused no detectable phenotypes at 
both temperatures tested (Figure 3-11,B).  
 I next tested the combined loss of SNL1 in the strain lacking both ribosome associated 
Hsp70 chaperones, Ssb1 and Ssb2 (ssb1∆ssb2∆). I was able to corroborate previous reports 
that cells lacking both SSB genes showed slower growth below 30 °C compared to the wild 
type cells as seen by the smaller colony size and growth defects of the double mutant, 
whereas cells lacking SNL1 showed no growth defect. Growth was not further impaired in 
the snl1Δssb1∆ssb2∆ at these temperatures (Figure 3-11,C). At temperature stress conditions, 
a slight synthetic growth defect is seen in the triple mutant at 37 °C and 39 °C. These results 
suggest that there is no genetic interaction between genes encoding SNL1 and the above 
mentioned ribosome associated chaperone genes and indicates that they may not be working 
in parallel or in partly overlapping pathways at the conditions tested. However, it is possible 
that during temperature stress, Snl1 and the ribosome associated Ssb may be involved 
together in de novo protein folding. 
Synergistic growth assay between snl1∆ and genes involved in translocation across the 
ER membrane 
 Full length Snl1 is attached to the ER membrane and as a result could be involved 
with protein translocation across the ER. To investigate this, I combined knockout mutations 
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FIGURE 3-11. snl1Δ  cells show no detectable synthetic growth phenotypes with RACΔ , 
NACΔ  and SSBΔ  strains. (A, B)  Wild-type (WT, BY4741) and indicated single and 
double-deletion cells were serially diluted and spotted onto plates containing YPD medium 
and incubated at the indicated temperatures for 2 days. (C) Wild-type (WT, DS10) and 
indicated mutants in the same genetic background were serially diluted and spotted onto 
plates as described above.  
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FIGURE 3-11. snl1Δ  cells show no detectable synthetic growth phenotypes with RACΔ , 
NACΔ  and SSBΔ  strains.  
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of SNL1 with deletions of non-essential subunits of the ER translocation pore, SBH1, SBH2, 
SSH1, SEC66 and SEC72. No detectable growth phenotypes were seen at both temperatures 
tested (Figure 3-12,A). The combined deletion of SNL1 from a sec61∆ strain complemented 
with a vector containing a wild type copy of SEC61 or a SEC61 temperature sensitive allele 
showed no discernable growth impairment suggesting that Snl1 may not be working in 
parallel with these genes at the conditions tested (Figure 3-12,B). 
Synergistic growth assay between snl1∆ and genes previously identified as synthetic in a 
genomic screen 
 As seen in (Figure 3-13), I was unable to recapitulate the synthetic phenotypes 
reported for SNL1 by a recently published high-throughput whole-genome screen (24). It is 
possible that this may be the result of false positives that may have arisen in the screen and 
will require further testing using conditions other than temperature. 
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FIGURE 3-12. snl1Δ  cells show no detectable synthetic growth phenotypes with genes 
involved in translocation across the ER membrane. (A) Wild-type (WT, BY4741) and 
indicated single and double-deletion cells were serially diluted and spotted onto plates 
containing YPD medium and incubated at the indicated temperatures for 2 days. (B) SNL1 
was deleted from a strain lacking SEC61 and complemented with a vector containing either a 
wild-type copy of SEC61 (psec61-WT) or a SEC61 temperature sensitive allele (psec61-
mutTS). Cells were serially diluted and spotted onto plates containing YPD medium and 
incubated at the indicated temperatures for 2 days. 
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FIGURE 3-12. snl1Δ  cells show no detectable synthetic growth phenotypes with genes 
involved in translocation across the ER membrane 
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FIGURE 3-13. snl1Δ  cells show no detectable synthetic growth phenotypes with genes 
previously identified as synthetic in a genomic screen. Wild-type (WT, BY4741) and 
indicated single and double-deletion cells were serially diluted and spotted onto plates 
containing YPD medium and incubated at the indicated temperatures for 2 days. 
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FIGURE 3-13. snl1Δ  cells show no detectable synthetic growth phenotypes with genes 
previously identified as synthetic in a genomic screen 
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TABLE 3-2 Genes exhibiting correlation with SNL1 expression identified via SPELL 
 
Rank Gene Common name Score 
1 YMR260C TIF11 2.4 
2 YIL008W URM1 2.4 
3 YHR013C ARD1 2.4 
4 YFR001W LOC1 2.4 
5 YPR187W RPO26 2.3 
6 YIL052C RPL34B 2.3 
7 YBR154C RPB5 2.3 
8 YER131W RPS26B 2.3 
9 YIL020C HIS6 2.3 
10 YMR194W RPL36A 2.2 
11 YBR252W DUT1 2.2 
12 YNL162W RPL42A 2.2 
13 YDL191W RPL35A 2.2 
14 YHR010W RPL27A 2.2 
15 YOR210W RPB10 2.2 
16 YGL031C RPL24A 2.2 
17 YOR276W CAF20 2.2 
18 YIL027C KRE27 2.2 
19 YJL124C LSM1 2.2 
20 YLR388W RPS29A 2.2 
21 YDR086C SSS1 2.2 
22 YOL139C CDC33 2.2 
23 YKR094C RPL40B 2.2 
24 YDL166C FAP7 2.2 
25 YGL232W TAN1 2.1 
26 YGR148C RPL24B 2.1 
27 YJL179W PFD1 2.1 
28 YGR195W SKI6 2.1 
29 YML094W GIM5 2.1 
30 YOL077C BRX1 2.1 
31 YGL070C RPB9 2.1 
32 YDR429C TIF35 2.1 
33 YIL021W RPB3 2.1 
34 YGR118W RPS23A 2.1 
35 YGR105W VMA21 2.1 
36 YDR045C RPC11 2.1 
37 YLR333C RPS25B 2.1 
38 YDR471W RPL27B 2.1 
39 YDR339C FCF1 2.1 
40 YDL075W RPL31A 2.1 
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41 YHR143W-A RPC10 2.1 
42 YDL092W SRP14 2.1 
43 YDR454C GUK1 2.1 
44 YGR085C RPL11B 2.1 
45 YMR242C RPL20A 2.1 
46 YOR293W RPS10A 2.1 
47 YER074W RPS24A 2.1 
48 YLR344W RPL26A 2.1 
49 YGR081C SLX9 2.1 
50 YLR325C RPL38 2.1 
*Correlation score is calculated for each gene in the genome based on correlation 
with the query gene SNL1 using the default settings of the SPELL server. 
(http://spell.yeastgenome.org/) Only the top 50 hits are shown. 
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3C. DISCUSSION 
 In this chapter, I report for the first time a novel interaction between the S. cerevisiae 
BAG domain-containing protein Snl1 and the ribosome and show that this interaction is 
conserved in the pathogenic fungus Candida albicans Snl1/Bag-1 homolog implying a 
conservation of function. Unlike the other cytosolic NEFs in yeast, Snl1 is unique in being 
the only known membrane-anchored Hsp70 NEF, and I found that ribosomes associate with 
both the membrane-bound and soluble truncated Snl1∆N isoforms. Thus, ER attachment 
does not block the ribosome-binding site and as a corollary, the localization of Snl1 at the 
membrane does not govern ribosome binding. As seen in Figure 3-2, all four NEFs readily 
associated with Hsp70 but Snl1 was unique amongst them in ribosome association.  
 The ribosome associated Hsp70, Ssb is unique to fungi, compared to other cell types 
and functions to fold nascent chains as they emerge from the ribosome exit tunnel. The 
ability of Snl1 to interact with both Ssb and the ribosome suggested that this ternary complex 
was Ssb-dependent. However, four separate results show that the interaction of Snl1 with the 
ribosome is independent of its association with Hsp70 and its function as an NEF. First, the 
strain lacking SSB1 and SSB2 had no effect on Snl1-ribosome interaction. Second, a 
previously characterized mutant of SNL1 having amino acid changes that abolish Hsp70 
interaction still retained ribosome binding. Third, the salt sensitivities of Snl1 with Hsp70 
(salt resistant) and Snl1 with ribosomes (salt sensitive) were different. Fourth, the ribosome-
binding surface in Snl1 within the predicted helix 1 (based on homology to mammalian Bag-
1 BAG domain) is distinct from the Hsp70-interacting residues localized in the predicted 
helices 2 and 3. From these data, ribosome-associated Snl1 would be predicted to serve two 
roles: (i) tether an Hsp70 chaperone to the ribosome and (ii) function as an NEF during 
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Hsp70-dependent protein folding. Genes encoding ribosomal proteins and their binding 
partners such as Ssb are frequently co-regulated at the transcriptional level. Using the Serial 
Pattern of Expression Levels Locator (SPELL) database, I found that SNL1 transcript levels 
were also co-regulated with ribosomal protein genes and support the idea that Snl1 is a 
bonafide ribosome binding protein and suggest that cells may regulate levels of Snl1 to 
correlate with the protein biosynthetic needs of the cell (Table 3-2). 
 Results from the mass spectrometry analysis and EDTA treatment of the Snl1-
ribosome complexes identified two important aspects of Snl1 binding to the ribosome. One, 
Snl1 interacts with assembled ribosomes since both large (60S) and small (40S) subunit 
proteins of the ribosome co-purified with Snl1. Two, Snl1 preferentially binds to the large 
ribosomal subunit via the lysine-rich region that I identified to be in the predicted helix 1 
domain and favor the model that it may bind in close proximity to Ssb, which is predicted to 
be present near the ribosome exit tunnel. Binding to ribosome by means of a positively 
charged stretch of amino acids seems to be a common binding strategy for ribosome-
associated proteins. The identification of a lysine-rich region in Snl1 is consistent with the 
arginine-lysine-rich region in the β-domains of the nascent chain associated complex (NAC) 
in yeast and mammals and the bacterial trigger factor (TF), which utilizes a similar charged 
interface to interact with ribosomes (70).  
 In this chapter, I show that ribosome binding by Snl1, the Bag-1 homolog in S. 
cerevisiae is not limited to this fungal species but that the Bag-1 homolog in the pathogenic 
fungus C. albicans, which is separated from S. cerevisiae by over 250 million years of 
separation can also bind ribosomes and is also localized to the ER/nuclear membrane, similar 
to Snl1. This suggests that Bag-1 homologs in fungi are important enough to be conserved 
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for this long. Interestingly, investigation of Bag-1 homologs in other species identified two in 
the genome of the fission yeast Schizosaccharomyces pombe, one having a transmembrane 
domain and one that lacks it but contains a lysine-rich region (Figure 3-9). In addition, the 
human Bag-1 protein is expressed as different isoforms by alternative translation initiation 
and analysis of the long isoform Bag-1L revealed a short, positively charged sequence at its 
N-terminus, which was absent in the small isoform used in my experiment (Figure 3-9). The 
hypothesis that these proteins can bind the ribosome needs to be tested and is therefore 
possible that cells may express Bag-1 isoforms with or without the ability to associate with 
ribosomes.  
 Given the location of Snl1 at the ER membrane, a role in the transport of proteins 
from the cytoplasm into the ER membrane or lumen can be envisioned. Because of the 
utilization of the signal recognition particle (SRP) pathway during co-translational 
translocation, it seemed unlikely that Snl1 would play a role in this pathway. On the contrary, 
certain proteins that are released into the cytoplasm and require Ssa1 binding to maintain 
their translocation-competent state do not require the SRP pathway for translocation across 
the ER membrane (posttranslational translocation). At least one protein, pre-pro-α-factor 
(ppαF) utilizes this pathway but preliminary analysis of ppαF processing failed to 
demonstrate a major defect in snl1∆ cells. The testing of a functional role for Snl1 in the cell 
is confounded by the lack of detectable functional phenotypes in cells lacking SNL1. Using 
genetics to detect synthetic growth phenotypes, I tested the loss of SNL1 in combination with 
RAC, NAC, SSB, ER translocation mutants and three genes identified to have synthetic 
growth defects with SNL1 as reported in a high-throughput whole-genome screen. In all 
cases, I was unable to detect any synthetic growth defects. It is likely that Snl1 plays a subtle 
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or condition-specific role in protein biogenesis. Identification of such a role will require 
unbiased genome-wide and/or proteome-wide studies and it is clear that significant additional 
work is required to understand the importance of the Snl1-ribosome association. 
Nevertheless, my discovery of Snl1 as a possible adaptor linking translating ribosomes and 
Hsp70 represents an important step in understanding the biology of BAG domain-containing 
proteins. 
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Chapter 4: Purification of the BAG domain of Snl1 for 
structural determination 
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4A. INTRODUCTION 
BAG domain-containing protein homologues are found in a variety of organisms 
including mice, Xenopus, Drosophila, Bombyx mori (silk worm), Caenorhabditis elegans, S. 
cerevisiae, Schizosaccharomyces pombe and Arabidopsis thaliana. Human members of this 
family include Bag-1, Bag-2, Bag-3 (CAIR-1/Bis), Bag-4 (SODD), Bag-5 and Bag-6 
(BAT3/Scythe). The BAG-1 gene encodes four isoforms with varying protein sizes (Figure 
4-1). All these proteins share the signature BAG domain near the carboxy-terminal end, 
except for Bag5, which contains five such domains. Interestingly, Bag proteins contain 
different N-terminal domain regions that dictate their specificity to protein partners or 
complexes in the cell and/or their localization. For example, all four Bag-1 isoforms and 
Bag-6 have an ubiquitin-like domain (UBL) at their amino-terminus. Although two isoforms, 
Bag-1 and Bag-1M have been shown to interact with the proteasome, the UBL domain of 
Bag-6 has not yet been linked to a partner protein or function (27). Bag-3 and Bag-6 contain 
a proline rich repeat, PXXP, which is a binding domain for proteins containing an Src 
homology 3 (SH3) motif. Unlike the mammalian Bag proteins that are all free floating in the 
cytosol, the fungal BAG domain-containing homologs Snl1 and CaSnl1 in S. cerevisiae and 
C. albicans respectively, are the only known members of this family to contain an N-terminal 
transmembrane domain and are localized at the ER membrane with majority of the C-
terminal BAG domain situated in the cytosol (Figure 4-1). However, the cellular role for 
membrane attachment is not known. 
Snl1 is the yeast homolog of mammalian Bag-1 and has been classified as a member 
of the BAG domain-containing family of Hsp70 NEFs by sequence analysis (139). In 2001, 
the crystal structure of the BAG domain of Bag-1M complexed with the NBD of bovine 
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Hsc70 was determined (Figure 4-2,A) (140). The structure revealed that the BAG domain 
formed a three-helix bundle with helices 2 and 3 making contacts with subdomains IB and 
IIB of the NBD. Binding of the BAG domain to the NBD resulted in a 14° rotation of domain 
IIB. Further, residues Glu-212 and Arg-237 located in helix 2 and helix 3 respectively of 
Bag-1 are required for Hsp70 interaction and conserved in BAG domain-containing proteins. 
The domain architecture of the BAG domain of Bag-4 is similar to Bag-1 and contains a 3-
helix bundle, however, in Bag-4, each helix in the bundle is three to four turns shorter than in 
Bag-1 (16). This reduces the length of the domain by one-third and structural comparison 
defines two sub populations of mammalian BAG proteins, those that contain a long form of 
the BAG domain (Bag-1) and those that contain a shorter form (Bag-3, Bag-4, Bag-5). As 
would be expected because of the shorter length of the helices in Bag-4, the contributions and 
relative importance of some residues that are involved in Hsp70 binding are different. Bag-5 
is unique because it contains five shorter BAG domains in tandem in which the fifth alone 
binds to the Hsp70 NBD. It is not known yet if the other BAG domains in Bag-5 contain a 
lysine-rich region, which could dictate ribosome interaction. One structure of Bag-5 with the 
NBD shows it to bind only subdomain IIB, similar to Bag-1, while another structure shows it 
to interact with both subdomains IB and IIB suggesting that either or both structures may 
contribute to Bag-5 binding to Hsp70 and its NEF activity (Figure 4-2,C) (5).  
Recently, the structure of Bag-2 was determined by X-ray crystallography (Figure 4-
2,B). Contrary to the three helix BAG domain present in Bag-1 and Bag-4, Bag-2 forms a 
dimeric structure, in which a flanking linker helix and loop mediates binding to Hsc70 to 
promote nucleotide exchange (Figure 4-2,B). This newly defined NEF domain called the 
‘brand new bag’ (BNB) also has low homology to BAG domains of other Bag family 
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members and the crystal structure revealed that conserved residues in other Bag proteins that 
contact the Hsp70-NBD are poorly conserved or mispositioned in Bag-2. Bag-2 causes the 
entire domain II of the NBD to rotate about linkages connecting subdomains IA and IIA 
(162). In addition, Bag-2 can directly bind to misfolded substrates and suppress their 
aggregation, unlike its other family members. NMR analysis shows that the substrate- and 
Hsc70-binding sites overlap and that Hsc70 can displace substrates from Bag-2-BNB 
indicating a distinct mechanism for Hsp70 binding and substrate folding by Bag-2. Taken 
together, the structures of the BAG domain of these proteins indicate that despite their ability 
to bind Hsp70, they all have slightly different conformations. 
My prediction that the ribosome binding site is present in helix 1 of the putative BAG 
domain of Snl1 was based on the structure of the mammalian BAG domain of Bag-1 (Figure 
4-2,A). In this structure, helices 2 and 3 face the NBD of Hsp70 and are unlikely to be able to 
bind the ribosome due to steric hindrance. It was plausible from this structure that helix 1 on 
the opposite side of these two helices would be available for binding other proteins. I have 
since shown that the putative helix1 of Snl1 binds the ribosome and that this binding is 
independent of its interaction with cytosolic Hsp70s, Ssa and Ssb. I have also shown that this 
interaction pattern is present in the closely related pathogenic fungus, Candida albicans, 
suggesting conservation of ribosome association by fungal Bag proteins.  
No evidence exists about the structural arrangement of the BAG domain of fungal 
Bag proteins. This chapter will present the preliminary steps of protein purification and 
analysis of Hsp70 binding to determine the minimal region of the Snl1 and CaSnl1 BAG 
domains that are required for Hsp70 interaction. The work presented here is the basis of an 
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active collaboration with Dr. Andreas Bracher at the Max Planck Institute for Biochemistry 
in Munich, Germany to determine the structure of the BAG domain in fungal Bag proteins.  
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FIGURE 4-1. Domain architecture of human and fungal BAG family proteins. The 
location of the BAG domain (blue) and other domains present in human and fungal BAG 
family members are indicated. Four isoforms of the Bag-1 protein are depicted on the top. 
Numbers beside the linear peptide sequence illustration indicate the length of each Bag 
protein.  
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FIGURE 4-1. Domain architecture of human and fungal BAG family proteins   
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FIGURE 4-2. Structural comparison of known BAG domains. Co-crystal structures of 
the BAG domain (red) of Bag-1 (A), Bag-2 (B) and the fifth BAG domain of Bag-5 (C) are 
shown with the ATPase domain of Hsp70 (green). Bag-1 and Bag-5 share a similar three-
helix bundle fold while Bag-2 contains a new fold termed “brand new bag.” PDB IDs: 1HX1 
(Bag-1), 3CQX (Bag-2) and 3A8Y (Bag-5). (5, 140, 162)  
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FIGURE 4-2. Structural comparison of known BAG domains  
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4B. RESULTS 
Suppression of sse1Δ  slow growth phenotype by Snl1 and CaSnl1 truncations 
An sse1Δ strain was shown previously to exhibit a slow growth phenotype at 30°C 
and 37°C (89). This growth anomaly is linked to its ability to act as an NEF for the cytosolic 
Hsp70s, Ssa and Ssb. Our lab has observed that the slow growth of an sse1Δ strain can be 
suppressed when cells moderately overexpress (greater than chromosomal expression) either 
of the other cytosolic NEFs, Sse2, Fes1 and Snl1ΔN, suggesting that they can replace Sse1 as 
a NEF for Hsp70-dependent functions in the cell. I utilized this growth assay to determine the 
minimal region of the BAG domain of S. cerevisiae (Snl1) and C. albicans (CaSnl1) that can 
suppress the slow growth phenotype observed in an sse1Δ strain. Each truncation of Snl1 and 
CaSnl1 was FLAG-epitope tagged and individually expressed in the sse1Δ strain. If a 
truncated protein were capable of performing NEF function, it would suppress the slow 
growth associated with the loss of Sse1. I checked suppression by these constructs at 
physiological (30°C) and heat-stressed (37°C) conditions (Figure 4-3). With the exception of 
the Δ80Snl1 mutant, the other truncations of Snl1 and CaSnl1 were able to suppress sse1Δ 
slow growth phenotype at 30°C. However, at 37°C only Δ60Snl1 and to a lesser extent 
Δ91CaSnl1 and Δ103CaSnl1 were able to suppress slow growth of sse1Δ cells. The inability 
of Δ70Snl1 to suppress the slow growth of sse1Δ cells at 37°C suggests that this protein is 
unable to bind Hsp70 and function as an NEF at high temperature, consistent with a defect in 
chaperone function. Residues between 60 and 70 may serve to stabilize the Hsp70-binding 
region of the BAG domain and loss of these ten residues destabilizes this domain at high 
temperatures.  
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FIGURE 4-3. sse1Δ  growth suppression assay. An sse1Δ strain expressing FLAG-tagged 
Sse1 and individual truncated mutants of Snl1 was serially diluted and spotted onto plates 
containing SC-HIS medium and incubated at the indicated temperatures for 40 hours.
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FIGURE 4-3. sse1Δ  growth suppression assay 
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Identification of the minimal region of Snl1 and CaSnl1 that can interact with Ssa and 
Ssb 
To test whether the truncated proteins that were expressed in the previous growth 
suppression assay were stably produced, I constructed expression vectors to produce FLAG-
tagged truncated variants of the proteins. I then affinity purified each protein using M2-
agarose resin from whole cell extracts of S. cerevisiae cells lacking SSE1. As a positive 
control, I used the previously described Flag-Sse1 protein that binds both Ssa and Ssb (131). 
This experiment was also performed to identify the minimal BAG domains of Snl1 and 
CaSnl1 that bind to Ssa and Ssb. With the exception of the Δ80Snl1 mutant, all the truncated 
proteins appear to be stably expressed (Figure 4-4). In addition, all but the Δ80Snl1 mutant 
retained binding to Ssa and Ssb as observed by Coomassie- dye staining suggesting that these 
truncations were properly folded. I noticed that the Snl1 proteins from both S. cerevisiae and 
C. albicans interacted with ribosome-associated chaperone Ssb stronger than Sse1 (Figure 4-
4). This may suggest that BAG domain-containing proteins have a preference for Ssb. This 
could be due to the small protein size of fungal Bag proteins compared to Sse1.  
Pilot purification of His6-Δ60Snl1 and His6-Δ103CaSnl1 
 How do fungal BAG domain-containing proteins bind Hsp70? Recent evidence of a 
different BAG domain structure of Bag-2 made us wonder if fungal BAG domains were 
structurally related to previously known BAG domains or were in a class of their own. From 
the previous data, it is evident that the stably expressed truncated mutants of Snl1 and CaSnl1 
that can bind both Ssa and Ssb in addition to suppressing the slow growth of sse1Δ cells at 
both temperatures tested are Δ60Snl1 and Δ103CaSnl1. As described in the Methods section, 
Δ60Snl1 and Δ103CaSnl1 were partially purified as N-terminally His6-tagged fusion proteins 
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from E. coli BL21 cells. Cell extracts expressing His6-Δ60Snl1 and His6-Δ103CaSnl1 were 
isolated using French Press (1200 psi) and incubated with Ni-NTA resin for two hours to 
facilitate binding. Proteins were purified using a gravity flow column. Most of the proteins 
present in the cell extract that did not bind the resin were collected in the flow-through (FT) 
fraction. The resin was washed once with low-ionic-strength buffer containing 5 mM 
imidazole, which removed almost all non-specifically bound proteins (W1). Both Δ60Snl1 
and Δ103CaSnl1 proteins were initially released from the Ni-NTA column using 50 mM 
imidazole (W3) and all bound proteins were released with 200 mM imidazole (E1) to near 
purity (Figure 4-5). 
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FIGURE 4-4. Stably expressed mutants of Snl1 and CaSnl1 bind to Ssa and Ssb. Whole-
cell extract from an sse1Δ strain expressing individual FLAG-tagged alleles of Snl1 (Δ60-
Δ80) and CaSnl1 (Δ91,Δ103) were subjected to FLAG immunoprecipitation and run on a 
10% SDS-PAGE gel (top panel) and 15% SDS-PAGE gel (middle panel). The bottom panel 
represents the load control. An empty vector (EV) and Flag-Sse1 were used as negative and 
positive controls respectively. CBB, Coomassie brilliant blue.  
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FIGURE 4-4. Stably expressed mutants of Snl1 and CaSnl1 bind to Ssa and Ssb 
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FIGURE 4-5. Pilot purification of His6-Δ60Snl1 and His6-Δ103CaSnl1. His6-tagged 
Δ60Snl1 and Δ103CaSnl1 were expressed in BL21 cells and affinity purified using Ni-NTA 
resin from cell lysates. Bound proteins were loaded onto a polyprep chromatography column. 
The flow through (FT) was initially collected followed by sequential wash steps (W1, W2, 
W3). Elution of bound protein was done in two steps (E1, E2). All fractions were run on a 
15% SDS-PAGE gel. CBB, Coomassie brilliant blue; TP, total extract.  
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FIGURE 4-5. Pilot purification of His6-Δ60Snl1 and His6-Δ103CaSnl1 
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4C. DISCUSSION 
 The primary goal of the work described in this chapter was to initiate a collaborative 
project to determine the structure of the fungal BAG domains from Saccharomyces 
cerevisiae and Candida albicans. Over the last few years, a number of BAG domain 
structures from different Bag proteins have been determined. Interestingly, all these 
structures show nuance differences in their binding surfaces with the NBD of Hsp70. The 
architecture of fungal BAG domain-containing proteins remains poorly defined and 
understanding how they interact with Hsp70 may provide clues to better understand their 
mechanisms and intracellular functions. In addition, my discovery of the ability of fungal 
BAG domains to also interact with the ribosome adds an additional impetus to determine 
how they assume their conformation with respect to Hsp70 and the ribosome. 
 It was previously shown that an sse1∆ strain is slow growing at the physiological 
temperature (30°C) and the growth defect is exacerbated during heat stress (37°C) (89). 
However, mild overexpression of the other NEFs present in the yeast cytosol can suppress 
this slow growth phenotype. The ability of these NEFs to overcome the growth defects 
associated with loss of SSE1 is due to functional redundancy and their ability to perform the 
same function as Sse1, namely nucleotide exchange. I used this assay to determine whether 
truncations of Snl1 and CaSnl1 proteins were able to suppress the growth defect of the sse1∆ 
strain. As seen in Figure 4-3, Δ60Snl1 and a lesser extent Δ91CaSnl1 and Δ103CaSnl1 
suppressed the slow growth of cells suggesting that at higher temperatures, Snl1 could 
efficiently perform its nucleotide exchange function while the CaSnl1 homologs were less 
efficient. This observation with CaSnl1 homologs could be a result of these proteins being 
expressed in S. cerevisiae. The inability of Δ70Snl1 to suppress the slow growth of sse1Δ 
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cells at 37°C suggests that this truncated protein is unable to perform nucleotide exchange at 
an elevated temperature. I also determined that suppression of slow growth of sse1Δ cells by 
these proteins was a result of their stable expression. With the exception of the Δ80Snl1 
mutant, all the truncated proteins appear to be stably expressed (Figure 4-4). In addition, all 
but the Δ80Snl1 mutant retained binding to Ssa and Ssb as observed by the Coomassie-
stained gel suggesting that these truncations were properly folded. Interestingly, the data 
show that Snl1 proteins from both S. cerevisiae and C. albicans interact with ribosome 
associated chaperone Ssb stronger than Sse1 and suggests a preference for this Hsp70 in the 
cytosol. Could this be related to the domain architecture of BAG domain-containing proteins 
since these proteins and Sse1 have different Hsp70 binding domains? One possibility is that 
the small size of the BAG domain (~13 kDa) compared to Sse1 (~100 kDa) could give Snl1 
proteins better access to Ssb present on the ribosome. Association of Sse1 with the ribosome 
has not been found, although Sse1 can associate with Ssb. It is possible that Sse1 may bind 
the small population of Ssb (30%) that is not associated with the ribosome. Since Ssb cannot 
replace most functions of Ssa, binding preferences of Snl1 and Sse1for the two classes of 
Hsp70 in the cytosol may result in their roles in specific Hsp70-dependent functions.  
 The structure of fungal Bag proteins is unknown and to initiate the process of 
determining their crystal structure, I designed and implemented a pilot purification strategy 
that would efficiently purify the minimal region of the BAG domain of Snl1 and CaSnl1 that 
could bind Ssa and Ssb (Figure 4-5). The constructs I made were sent to our collaborator for 
further large-scale purification and crystal structure determination. I predict that the Hsp70 
binding domain of these proteins will be consistent with the known BAG domain structure of 
Bag-1 and contain a three-helix bundle, as residues within this region were also conserved in 
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the human Bag-1 protein. However, the ribosome-binding site within these proteins might 
resemble a short helical or loop region that is not part of the rigid structure of the BAG 
domain and thus makes it more facile for ribosome interaction. Since Snl1 is a small 
membrane-bound protein, binding to the large ribosomal complex and Hsp70 may be 
difficult due to steric hindrance effects. A more flexible loop region may subvert these steric 
effects. In addition to providing a structural explanation for the ability of Snl1 to bind the 
ribosome and Hsp70, mutagenic confirmation of predicted structural details can be 
performed. 
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Chapter 5: Specificity of Fes1 binding to Hsp70 
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5A. INTRODUCTION 
Fes1 was first identified in a yeast genome-wide screen looking for homologs of Sil1, 
an NEF of Kar2, the resident Hsp70 of the endoplasmic reticulum (ER). Fes1 is related to the 
mammalian NEF HspBP1 (38% similarity and 25% identity) and binds to and performs 
nucleotide exchange for Ssa in vivo and for both Ssa and Ssb in vitro (32). Additionally, the 
FES1 gene is required for growth at high temperatures suggesting its important role as an 
Hsp70 co-chaperone during cellular stress due to elevated temperatures. Structural 
determination of the conserved core domain of human HspBP1 (BP1c) that binds Hsp70 and 
shares a similar domain with Fes1, revealed a unique architecture amongst NEFs. The 
domain is composed of four Armadillo-like repeats that is strikingly different from the three-
helix bundle of the BAG domain (Figure 5-1). Compared to the BAG domain, which binds to 
the central cleft between domains I and II, BP1c associates with lobe II from the side and 
wraps around subdomain IIB of the NBD and is suggested to displace lobe I due to steric 
hindrance (134).  
In vitro experiments showed that Fes1 binds more efficiently to the ADP-bound state 
of Ssa1 and rapidly decreased (within 1 min) the amount of bound nucleotide on Hsp70. This 
classifies Fes1 in the same group of NEFs like Sil1 that preferentially binds to the ADP-
bound state of Hsp70. A double mutation in Fes1 (A79R/R195A) abolished its interaction 
with Ssa1 and was unable to complement the deletion of FES1 at high temperatures, 
indicating that a direct interaction between these two proteins is required for function (134). 
Fes1 was shown to inhibit the ATPase activity of Ssa1 in the presence or absence of Ydj1, a 
Hsp40 of Ssa1 that stimulates Ssa1 ATPase activity. This observed inhibition by Fes1 is 
expected since the removal of bound nucleotide in Ssa1 will decrease the apparent rate of 
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ATP hydrolysis. Binding of Fes1 to ribosome-associated Hsp70, Ssb1 was determined using 
His6-tagged Fes1 purified from E. coli and incubated with S. cerevisiae cell lysate. 
Interacting proteins were isolated by affinity purification of Fes1. The recombinant double 
mutant of Fes1 that could not interact with Ssa1 also could not associate with Ssb1, 
suggesting that the interface of Fes1 that binds Ssa1 and Ssb1 is similar. The binding affinity 
of the complex between Fes1 and Ssa1 or Ssb1 was determined using surface plasmon 
resonance. Using this method, Fes1 had a slightly higher affinity for Ssb1 (Kd ~87 nM) 
compared to Ssa1 (Kd ~193 nM). These values are slightly higher than those determined for 
BP1c and the BAG domain of Bag-1 with the NBD of mammalian Hsp70 (Kd 62 and 41 nM 
respectively) (134).  
A heterodimeric complex called the ribosome associated complex (RAC) consisting 
of the non-canonical Hsp70, Ssz1 and Hsp40, Zuo1 functionally cooperates with Ssb to 
stimulate Ssb ATPase activity. An in vitro experiment using purified proteins to test whether 
Fes1 function as an NEF could further stimulate the ATPase of Ssb in the presence of RAC 
revealed that Fes1 decreased Ssb1 activity even though Fes1-Ssb affinity was unchanged 
(32). Based on this evidence, it was proposed that RAC might interfere with binding of Fes1 
to Ssb but the direct binding of Fes1 to the Ssb-RAC complex was not assessed.  
 The function of Fes1 in binding to and releasing bound nucleotide from Ssa and Ssb 
has been primarily based on in vitro evidence using purified proteins. Although these 
experiments confirm a direct interaction between Fes1 with Ssa and Ssb, there is no in vivo 
evidence of Fes1 binding to these Hsp70s. This chapter will present data that shows Fes1 
interacts exclusively with Ssa proteins in vivo using a functional FLAG-Fes1 construct and 
provides preliminary data to test how Fes1 is restricted to Ssa chaperones.  
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FIGURE 5-1. Structural comparison of Hsp70 binding domains of HspBP1 and Bag-1. 
(A) Co-crystal structure of the conserved core domain of HspBP1 (red) in complex with 
subdomain IIB of the Hsp70 ATPase domain (green) showing the Armadillo-like repeats. (B) 
Co-crystal structure of the three-helix bundle BAG domain (red) of Bag-1 with the ATPase 
domain of Hsp70 (green). Top views are shown for both structures and aligned for 
superposition of subdomain IIB in the ATPase domain.  PDB IDs: 1XQS (HspBP1), 1HX1 
(Bag-1). (134, 140) 
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FIGURE 5-1. Structural comparison of Hsp70 binding domains of HspBP1 and Bag-1 
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5B. RESULTS 
In vivo interactions of Fes1 with Ssa and Ssb 
 Two separate groups showed that tagged-Fes1 purified from E. coli interacted with 
Ssa and Ssb. The Brodsky group utilized a glutathione-s-transferase (GST) tag on Fes1 to 
determine direct binding of Fes1 with purified Ssa using a GST pull-down assay (63). The 
Hartl group utilized a different approach. His6-Fes1 was incubated with cell lysate isolated 
from S. cerevisiae and binding partners of Fes1 were isolated after co-purification on Ni-
agarose resin (32). Using this method, His6-Fes1 was shown to interact with both Ssa1 and 
Ssb1. However, in both these cases, Fes1 was not expressed in yeast cells. To determine the 
co-purifying partners of Fes1 in a yeast cell, I constructed an expression vector to produce 
low amounts of FLAG-tagged Fes1 (above chromosomal expression levels) in a wild type 
yeast strain (BY4741). I affinity purified Fes1 using M2–agarose resin from yeast cell 
extracts as described in Materials and Methods (Chapter 2). Our lab has previously shown 
that this purification method works efficiently in yeast to determine chaperone interactions in 
yeast cells. In addition to Fes1, I independently expressed a FLAG-tagged Sse1 fusion using 
an identical promoter to compare Hsp70 interaction patterns. As shown in (Figure 5-2), Fes1 
expressed in a wild-type yeast strain appears to associate specifically with Ssa with little to 
no Ssb co-purifying with it as determined by Coomassie-dye staining. To confirm this, I 
performed a Western blot for Ssa and Ssb, which showed that Fes1 interacted exclusively 
with Ssa1. This result is in contrast to previously described interactions of Fes1 with Ssa and 
Ssb and suggests that in yeast cells, Fes1 does not associate with Ssb. This is the first 
reported evidence of a cytosolic NEF to exhibit selectivity in binding cytosolic Hsp70s.  
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FIGURE 5-2. Fes1 binds predominantly to Ssa in vivo. Amino-terminally FLAG (F)-
tagged Sse1 and Fes1 were individually expressed and immunoprecipitated from wild type 
(BY4741) whole-cell lysate. Immunoblot analysis was used to detect interacting proteins 
using anti-Ssa and anti-Ssb antisera. The positions of Fes1, Sse1, Ssa and Ssb are indicated in 
the Coomassie brilliant blue (CBB) stained SDS-PAGE gel. IB, immunoblot of the whole-
cell lysate. 
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FIGURE 5-2. Fes1 binds predominantly to Ssa in vivo   
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In vitro interactions of FLAG-Fes1 with Ssa and Ssb 
 In the experiment described above, Fes1 was FLAG-epitope tagged while the Fes1 
proteins used previously contained two different epitope tags, GST and His6. To test the 
possibility that the selective binding of Fes1 for Ssa was not due to the different tag, I 
constructed an E. coli expression vector to produce FLAG-Fes1 in E. coli. I successfully 
purified FLAG-Fes1 from E. coli to apparent homogeneity (1 mg/ml)(data not shown). 
Keeping the concentration of E. coli purified FLAG-Fes1 (3 µg/µl) constant in each sample, 
a different concentration of cell lysate extracted from S. cerevisiae was added to each Fes1 
sample and incubated for 2 hours to facilitate complex formation. I affinity purified Fes1 
using M2–agarose resin and observed that FLAG-Fes1 bound both Ssa and Ssb (Figure 5-3). 
This suggests that the tag used in these experiments does not play a role in binding to specific 
cytosolic Hsp70s. It is possible that Fes1 expressed in yeast may undergo a posttranslational 
change that is absent when it is produced in E. coli. This could alter the Fes1 protein and 
prevent its interaction with Ssb. Alternatively, factors present in the yeast cytosol may 
prevent Fes1 binding to Ssb. 
Overexpressing Fes1 in the cell still occludes binding to Ssb 
 Because the above data suggest that Fes1 is precluded from binding Ssb in a yeast 
cell, I first wanted to determine if the amount of Fes1 present in the cell could be a 
determining factor. A large-scale analysis of the global protein expression in yeast 
determined that Fes1 is present at 13,100 molecules/cell compared to Sse1, which is present 
at 71,700 molecules/cell and binds Ssb (45). To test this hypothesis, I made constructs of 
FLAG-Fes1 using two vectors that would moderately (~2-fold) and highly (~15-20-fold) 
overexpress Fes1 in a wild type yeast strain. Fes1 proteins were affinity purified using M2 
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FIGURE 5-3. Fes1 stably interacts with both Ssa and Ssb in vitro. (A) FLAG-Fes1purity. 
(B) Purified FLAG-Fes1 (3 µg/µl) incubated for two hours with 0, ~4.5 µg/µl and ~7.5 µg/µl 
of yeast whole-cell lysate was immunoprecipitated using M2 FLAG resin. Bound proteins 
were eluted as described in Materials and Methods, and immunoblot analysis was performed 
to detect interacting proteins with anti-Ssa and anti-Ssb antisera. Lysate added to M2 FLAG 
resin alone served as a control (lane 2). TPE, total extract.  
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FIGURE 5-3. Fes1 stably interacts with both Ssa and Ssb in vitro  
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agarose resin and their interactions with Ssa and Ssb was determined by a Western blot using 
α-Ssa and αSsb. Increasing the level of Fes1 in the cell still did not facilitate Fes1 interaction 
with Ssb. Interaction of Ssa with Fes1 was concurrent with Fes1 expression levels in the cell 
(Figure 5-4). This suggests a very distinct bias of Fes1 for cellular Ssa (Figure 5-3).  
RAC does not prevent Fes1 binding to Ssb 
 It was previously proposed that RAC present at the ribosome interferes with the 
binding of Fes1 to Ssb (32). To determine if the RAC proteins prevented the interaction of 
Fes1 with Ssb in cells, I expressed FLAG-Fes1 in a strain that lacked either SSZ1 or ZUO1. 
Fes1 was affinity purified from these two strains using M2 agarose resin and the association 
of Fes1 with Ssa and Ssb was determined by a Western blot using α-Ssa and α-Ssb (Figure 
5-5). The interaction of Fes1 with Ssa was unaffected in the absence of either RAC protein. 
The amount of Ssb that co-purified with Fes1 in each mutant strain was similar to wild type, 
but not above background (EV lane). These results indicate that neither RAC protein 
prevents the association of Fes1 with Ssb and suggests an alternative mechanism that 
prevents Fes1 binding to Ssb. 
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FIGURE. 5-4. Overexpressing Fes1 does not facilitate interaction with Ssb. Whole-cell 
lysate from a wild-type (WT) (BY4741) strain expressing either the empty vector (EV) or 
FLAG-Fes1 from a low copy (low) or high copy (high) plasmid was subjected to FLAG 
immunoprecipitation (IP). Interacting proteins were detected with anti-Ssa and anti-Ssb 
antisera.  
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FIGURE. 5-4. Overexpressing Fes1 does not facilitate interaction with Ssb 
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FIGURE 5-5. RAC does not prevent Fes1-Ssb interaction Whole-cell lysate from an 
ssz1Δ, zuo1Δ or wild-type (BY4741) strain expressing FLAG-Fes1 was subjected to FLAG 
immunoprecipitation (IP). Interacting proteins were detected on a Coomassie-stained gel 
(above) or by immunoblotting for Ssa and Ssb (below). 
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FIGURE 5-5. RAC does not prevent Fes1-Ssb interaction   
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5C. DISCUSSION 
 In this chapter, I present the first evidence of an in vivo bias in binding between a 
cytosolic NEF and a cytosolic Hsp70. I found that in yeast cells, Fes1 does not bind Ssb. This 
is in contrast with a previous published report that demonstrated Fes1 binding to Ssb and 
functioning as an NEF of Ssb in vitro. I found that Fes1 purified from E. coli and incubated 
with cell extract isolated from yeast bound both Ssa and Ssb, corroborating previous data. 
This difference in binding to Ssb whether Fes1 is expressed in E. coli versus S. cerevisiae is 
intriguing and in this chapter, I present preliminary data to test how Fes1 is restricted to Ssa 
chaperones. First, I overexpressed Fes1 in yeast cells to determine if the stoichiometry of the 
protein relative to Ssb could explain the observation. I found that even when Fes1 was 
expressed at very high levels, as a measure of the amount of Ssa that interacted with it, Fes1 
failed to interact with Ssb, suggesting that this inability to bind Ssb is not due to low affinity 
coupled with low concentrations. Next, I tested if components of the ribosome associated 
complex (RAC), Ssz1 and Zuo1 interfered with Fes1 binding to Ssb since both proteins are 
present with Ssb at the ribosome. In cells lacking SSZ1 or ZUO1, Fes1 was still unable to 
physically interact with Ssb.  
 The results presented in this chapter represent a preliminary follow-up of my original 
discovery of Fes1 binding to only cytosolic Hsp70, Ssa (as shown in Chapter 3). However, 
there are still many questions that need to be answered for why Fes1 has a bias towards one 
specific Hsp70. Preliminary data from our laboratory indicate that overexpressing Ssb can 
increase the amount of Ssb that copurifies with Fes1 (Gibney P, personal communication). 
This would suggest that during some cellular stress conditions, an increase in SSB 
transcription would then favor Fes1 binding to Ssb. If this were true, under the normal 
! 128!
growth conditions that I was using to test this interaction, Fes1 would not bind Ssb. This 
possibility is consistent with the observation that cells lacking FES1 are sensitive to the 
translation inhibitor cycloheximide and that Fes1 co-migrates with polysomes upon cellular 
fractionation (63). While this would suggest an Ssb-dependent function, a small population 
of Ssa exists at the ribosome through its physical association with poly(A)-binding protein, 
Pab1 and another ribosome-associated Hsp40, Sis1 (56). In addition, a temperature sensitive 
strain of SSA (ssa1-45) demonstrates a severe translational defect (8). This evidence along 
with the discovery that Fes1 specifically binds Ssa suggest that Fes1 migration with 
polysomes as shown previously may be Ssa-dependent. A comprehensive phenotypic 
analysis of a fes1∆ strain compared to an ssb1∆ssb2∆ strain will shed light on which 
phenotypes are shared between the two proteins, utilizing conditions such as cold and salt 
sensitivity, and sensitivity to the protein folding inhibitor canavanine. Cells deficient in Ssa 
chaperones do not share these phenotypes, thus making them a diagnostic for Ssb function 
alone. In addition, the role of Fes1 with respect to only Ssa-dependent functions such as 
protein translocation and protein folding need to be assessed. Initial analysis showed that 
Fes1 is not involved in the translocation of ppαF and in refolding the model substrate, firefly 
luciferase (Abrams et al., unpublished data). However, it is possible that Fes1 might be 
substrate- and cellular pathway-specific with respect to binding Ssa1 similar to that observed 
with the plethora of J proteins present in the cell (67). Finally, to test if Fes1 is differentially 
modified when produced in yeast versus E. coli, comparative mass spectrometry on both 
Fes1 proteins needs to be performed to identify any posttranslational modifications including 
phosphorylation and acetylation, both of which are well known modifiers of protein behavior 
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in the cell. This work provides a foundation to further investigate the functional roles of Fes1 
in the cell. 
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Chapter 6: Conclusions and perspectives
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Summary and conclusions 
Proper folding of cellular proteins is crucial for survival and the assistance of 
molecular chaperones or ‘heat shock proteins’ in preventing protein misfolding is vital. In 
mammalian cells, approximately 180 different chaperones and co-chaperones form a 
complex folding network that helps maintain the conformational integrity of the cellular 
proteome (52). The Hsp70 protein family plays an important role in this network. In addition 
to participating in co- and post-translational folding of newly synthesized proteins, Hsp70s 
are also involved in protein assembly, refolding of stress-denatured proteins, protein 
degradation, transport of proteins across cellular membranes such as the ER and 
mitochondria and in the regulation of protein substrates involved in signal transduction. 
However, Hsp70s do not perform this plethora of cellular functions by themselves, but 
depend on the function of J-proteins and NEFs, which regulate their nucleotide-dependent 
folding cycle and thereby their substrate binding ability.  
 In the present study, I focused on two classes of NEFs in yeast: Snl1 and Fes1. My 
experiments with Snl1 lead to the identification of a novel ribosome interaction site in BAG 
domain-containing proteins in fungi and I found that this interaction was independent of Snl1 
binding to cytosolic Hsp70s, Ssa and Ssb. Furthermore, I discovered that Fes1 bound 
specifically to Ssa with little to no interaction with ribosome-associated Hsp70, Ssb. These 
two lines of investigation highlight the first evidence of a novel ribosome association among 
fungal BAG domain-containing proteins and the first distinct binding specificity of an NEF 
with a cytosolic Hsp70. 
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Fungal BAG domain containing proteins bind ribosomes  
 At the outset of these studies, Snl1 in S. cerevisiae was identified as a homolog of the 
human BAG domain-containing protein, Bag-1 (139). Like Bag-1 in human cells, Snl1 
interacts with free-floating, cytosolic Hsp70, Ssa. In addition, Snl1 was shown to interact 
with the fungal-specific, ribosome-associated Hsp70, Ssb (139). However, both these 
interactions were determined in vitro using recombinant Snl1 that lacks its N-terminal 
transmembrane domain (Snl1ΔN). To characterize the cellular role of Snl1, I first sought to 
determine its binding partners in the cell. I did this by expressing FLAG-epitope tagged Snl1 
in yeast, which allowed me to immunoprecipitate it from cell extracts and identify co-
purifying proteins. I found that full length, membrane-associated Snl1 and free-floating 
Snl1ΔN bound to Ssa and Ssb. In addition, both Snl1 proteins also physically interacted with 
the assembled ribosome. However, this specific interaction with the ribosome is not seen 
with Bag proteins in higher eukaryotes. In humans, there are eight BAG domain-containing 
proteins that can bind different protein partners apart from Hsp70. This is accomplished by 
different N-terminal motifs located upstream of the Hsp70-binding BAG domain, which 
serves to target Bag proteins to their substrates (Figure 4-1). For example, the ubiquitin-like 
(UBL) domain present in Bag-1 and Bag-1M was shown to be responsible for co-
immunoprecipitating the Bag proteins with the 20S core and the 19S subunit of the 
proteasome. This suggests that both Bag proteins perform an adapter-like function linking the 
protein degradation machinery with Hsp70. Bag-1 is the only known BAG domain-
containing protein to also utilize the BAG domain to bind a substrate. Bag-1 interacts with 
the serine/threonine kinase Raf-1 or Hsc70 in a mutually exclusive manner (141). When 
Hsp70 levels increase during cellular stress, they compete with Raf-1 for binding to Bag-1, 
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which leads to lower Raf-1 signaling and subsequent inhibition of DNA synthesis and cell 
cycle arrest. This suggests that Bag-1 acts like a molecular switch that enables cell 
proliferation in normal conditions and cell growth inhibition during a stressful environment. 
These results support the idea that in addition to binding the NBD of Hsp70, BAG domain-
containing proteins can also bind other cellular substrates through their N-termini or directly 
through their BAG domains.  
Conservation in fungal BAG domain proteins with ribosome association 
How widespread in fungi is this interaction between the S. cerevisiae BAG domain-
containing protein and the ribosome? To answer this, I examined the sole Snl1 homolog in 
the pathogenic fungus, Candida albicans. S. cerevisiae and C. albicans are separated by 
more than 250 million years and it seemed appropriate to test if another fungal BAG domain-
containing protein could bind the ribosome. Utilizing a similar copurification method, I 
found that the C. albicans Snl1 homolog (CaSnl1) also associated with the ribosome, 
suggesting a common evolutionary function for these proteins to bind the ribosomal 
complex. However, this specific interaction with the ribosome has not yet been identified in 
Bag proteins in higher eukaryotes. The genome of the fission yeast Schizosaccharomyces 
pombe contains two putative BAG domain-containing proteins; bag102, which contains a 
putative N-terminal transmembrane domain and bag101 that contains a short positively 
charged string of residues. This suggests that in S. pombe, the transmembrane domain and 
ribosome binding are not connected and may function in distinct cellular pathways. The 
human BAG domain family consists of six members; Bag-1 to Bag-6. The Bag-1 gene 
encodes four isoforms of the Bag-1 protein expressed through alternative translation 
initiation sites. Bag-1L is located primarily in the nucleus while Bag-1, Bag-1M and Bag-1S 
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are localized to the cytoplasm. The human Bag-1 isoform that was used in this study 
(Chapter 3) was the shortest isoform, Bag-1S. Sequence analysis of Bag-1M and Bag-1L 
reveal a short, positively charged sequence at their N-terminal that is absent in Bag-1S 
(Figure 3-9). Therefore, it is possible that mammalian cells may express distinct Bag-1 
isoforms with or without the capacity to associate with ribosomes. 
BAG domain proteins interact with the ribosome through a short lysine-rich region 
 The results in Chapter 3 show that S. cerevisiae and C. albicans BAG domain-
containing proteins interact with the ribosome through a short sequence of lysine-rich 
residues. This region was first identified in Snl1 during a sequential N-terminal deletion 
analysis of the BAG domain to determine the ribosome-binding site. These lysine residues in 
Snl1 had not been previously assigned a function. Based on homology to mammalian Bag-1, 
this region of Snl1 lies in putative helix 1 of the anti-parallel BAG domain. Recent data on 
the heterodimeric nascent chain-associated complex (NAC) showed a short region of 
positively charged residues located at the amino-terminus of each β-subunit that mediated 
ribosome association (158). A similar charged interface is utilized by bacterial trigger factor 
(TF) to bind ribosomes, which enables the protein to bind nascent chains emerging from the 
ribosome (114). Interestingly, SecA, the motor protein in E. coli that assists in 
posttranslational substrate translocation across the bacterial membrane was shown to 
associate with ribosomes utilizing two lysine residues (59). These discoveries show that 
proteins interacting with the ribosome only require a short positively charged region. My 
discovery of the cytosolic NEF, Snl1 in fungi to associate with the ribosomal complex is the 
first of its kind for Hsp70 NEFs.  
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Structural determination of the fungal BAG domain 
How does the small size of the BAG domain of Snl1 (~110 amino acids) 
accommodate binding to Hsp70 and to the large ribosome complex? The ribosome-binding 
region in the β-subunit of NAC proteins is located in an exposed loop of a predicted helix-
loop-helix motif. This strategy to bind ribosomes is similar to trigger factor in bacteria. In 
both cases, the binding region is localized in a flexible loop region that is flanked by two α-
helices. From these two structures, it seems like a trend is emerging for ribosome associated 
chaperone domains; an exposed loop of positively charged residues inserted between α-
helical structures. Whether BAG domain proteins in fungi follow this trend or are in a 
structural class of their own needs further evaluation and our lab has initiated a collaboration 
to determine the structure of Snl1∆N and CaSnl1ΔN. It will be interesting to determine if the 
Snl1 BAG domain forms a rigid three-helix bundle structure like the human Bag-1 protein. A 
recent crystal structure of Bag-2 shows a new domain conformation termed “brand new 
BAG” (BNB), which forms a dimer with each monomer contacting an Hsc70 NBD by 
binding to subdomains Ib and IIb in an end-on fashion (162). In addition to its NEF function, 
the BNB domain is able to interact with hydrophobic residues of a short polypeptide 
sequence derived from the cystic fibrosis transmembrane conductance regulator (CFTR) 
protein. Since substrate- and Hsc70-binding sites on this domain overlap, Bag-2 might 
coordinately transfer substrate peptides to the substrate-binding domain (SBD) of Hsc70. 
Alternatively, Bag-2 might by recruited to Hsp70-client complexes through its ability to bind 
substrates. Determining the structure of Snl1 and CaSnl1 would shed light on whether BAG 
domain folds are also conserved in fungi.  
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Snl1 binds to the large subunit (60S) of the ribosome 
Ribosomes are composed of two subunits, each containing RNA and protein. The 
large subunit (60S) of the eukaryotic ribosome consists of three rRNAs (25S, 5.8S and 5S) 
and 46 proteins while the small subunit (40S) includes one rRNA (18S) and 33 proteins (68). 
While the small subunit is responsible for proper codon-anti-codon recognition and mRNA 
surveillance, the large subunit contains the active site where new peptide bonds are created 
during protein synthesis and the exit tunnel through which the polypeptide exits. Snl1-
ribosome complexes were treated with EDTA to dissociate the 80S-assembled ribosome into 
its subunits and then determine which ribosomal subunit Snl1 binds. I found that Snl1 
predominantly binds to the 60S large ribosomal subunit. Previous data shows that both signal 
recognition particle (SRP) and NAC bind to the large ribosomal subunit near ribosomal 
protein L23 and that SRP and NAC can interact directly with each other and compete for 
nascent polypeptide access (158). This is because protein L23 is situated near the polypeptide 
exit tunnel of the ribosome. Some secretory polypeptides require NAC to efficiently interact 
with SRP, whereas others are prevented from interacting with SRP when NAC is present 
(26). Thus, the observation that different factors compete with each other for binding to L23 
and the fact that Snl1 preferentially binds to the large subunit may add another layer of 
complexity in substrate recognition between proteins that bind near the ribosome exit tunnel. 
Identification of the exact binding site of Snl1 on the large ribosome subunit by crosslinking 
experiments could determine if Snl1 adds to the binding dynamics that exists between these 
non-homologous ribosome binding factors at the exit tunnel. On the contrary, Zuo1, the J 
domain protein component of the RAC complex that stimulates the ATPase activity of Ssb, 
was shown to bind the ribosome near the large subunit ribosomal protein L31, also situated at 
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the ribosome exit tunnel. Interestingly, it was previously suggested that the aminopeptidase 
from Mycobacterium tuberculosis might interact via a tandem proline-rich repeat motif, 
PXXP, with the Src homology 3 (SH3)-domain of the conserved large subunit ribosomal 
protein L24, a protein located in the vicinity of the chaperone-docking site L23 (2). The 
human BAG domain-containing protein, Bag-3 contains several PXXP motifs upstream of 
the BAG domain and it will be interesting to discern if this protein can bind the ribosome. 
I predict that Snl1 will interact at or near the ribosome exit tunnel and as a result may 
function to recruit cytosolic Hsp70, Ssa to sample nascent polypeptides emerging for the 
ribosome. The position of Ssb near the ribosome exit tunnel suggests that Snl1 might be 
utilized as an NEF of Ssb for specific substrates. The hypothesis that Snl1 can directly 
interact with nascent polypeptides chains also needs to be investigated. Since both large and 
small subunits of the ribosome co-purify with Snl1, it is possible that Snl1 associates with an 
intact translating ribosome but further work will have to be done to test this. 
Snl1 binds to ribosomes independently of Hsp70 
 Using three different approaches, I was able to provide evidence that the interaction 
of Snl1 with the ribosome was independent of its association with Hsp70 and its function as 
an NEF. However, the functional basis for this separation in binding is unknown. Snl1 might 
be recruiting Hsp70 to ribosomes, inviting comparisons to the recruitment of Ssb by RAC in 
fungi and more recently, the recruitment of cytosolic Hsp70 in mammals by the Zuo1 
ortholog, Mpp11 (58). In both cases, the ribosome associated proteins served to (i) tether an 
Hsp70 to the ribosome and (ii) perform its function as a J protein to stimulate the ATPase 
activity of Hsp70. Snl1 might also fulfill both roles. 
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Genes encoding ribosomal proteins and other components of the translational 
machinery display coordinated regulation in response to environmental changes. This allows 
efficient adjustment of the protein synthetic capability of the cell. For example, upon carbon 
upshift the mRNA levels for ribosomal proteins increase and upon amino acid starvation, the 
mRNA levels for these proteins are decreased. It was shown that the mRNA levels of Ssb, 
the ribosome associated chaperone are co-regulated with ribosomal protein encoding mRNA 
under three different growth conditions tested (74). Using the Serial Pattern of Expression 
Levels Locator (SPELL) database, I found that SNL1 mRNA levels correlated with those of 
ribosomal protein genes when queried over all available data sets (Table 3-2). This evidence 
along with the physical association of Snl1 with Ssb and the ribosome supports the 
contention that Snl1 is a component of the translational apparatus and suggests that cells may 
regulate the levels of Snl1 to match protein biosynthetic needs.  
Functional roles for Snl1 at the ER membrane 
What roles might Snl1 play while tethered to the endoplasmic reticulum (ER) 
membrane and associating with ribosomes? Determining the function of Snl1 in the cell is 
confounded by the lack of a detectable phenotype associated with cells lacking the protein. 
However, some speculations can be made on how Snl1 might function to bridge its 
interactions with Hsp70 and the ribosome. Because of the unique location of this Hsp70 NEF 
at the ER membrane, a role in protein translocation from the cytosol into the ER membrane 
or lumen can be envisioned. However, since co-translationally translocated proteins are 
recruited to the ER membrane in a signal recognition particle (SRP)-dependent manner, it 
seems unlikely that Snl1 would play a role in this pathway. In contrast, post-translationally 
translocated proteins must be directed to the ER translocon for import and require Hsp70/Ssa 
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binding while in the cytosol. Snl1 might serve to recruit an Ssa-substrate complex to the ER 
membrane through its Hsp70 binding site and in the process help to target non-SRP 
dependent substrates to the ER membrane. Testing this hypothesis is inhibited by the lack of 
a detectable phenotype for snl1∆ cells. In apparent disagreement with this idea, preliminary 
analysis of pre-pro-α-factor, a known post-translationally translocated substrate of Ssa1 
showed no major defect in translocation in snl1∆ cells. However, other posttranslational 
substrates cannot be ruled out. Another area for investigation would be to test whether Snl1 is 
required for the translocation of membrane-tethered secretory pathway-dependent proteins 
that either remain in the ER or are secreted to the outer membrane. In line with this, Snl1 
might function as an ER-localized NEF that assists Hsp70 to maintain and properly fold 
cytosolic domains of integrated ER membrane proteins. 
 Because Snl1 interacts with several ribosomal proteins, an area for investigation 
would be to test whether Snl1 plays a role in ribosome biogenesis. It was previously shown 
that ribosome-associated Hsp40, Jjj1 co-migrates with 60S ribosome subunits when total 
cellular extract from wild type yeast cells was separated on a sucrose gradient (83). This co-
migration was related to ribosome biogenesis where exit and subsequent re-entry of 
biogenesis factors from the nucleus shuttled pre-60S particles into the cytosol for maturation. 
Since Snl1 preferentially binds the 60S ribosomal subunit (Chapter 3) and is tethered to the 
ER/nuclear membrane, a role in ribosome biogenesis is suggested. One way to test this would 
be to compare the growth of the individual mutants with the combined deletion of SNL1 and 
JJJ1 to assess synthetic growth defects. In cells lacking ribosome-associated components 
(RAC-Ssb and NAC), a reporter construct with a GFP-tagged ribosomal protein, L25, was 
visualized in the nucleus, indicating defects in assembly and export of pre-60S subunits into 
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the cytoplasm. This protein incorporates into the mature ribosome and therefore the 
fluorescent signal should be seen in the cytosol. Nuclear or cytosolic accumulation of this 
reporter in snl1∆ cells will determine if Snl1 is involved in ribosome biogenesis. In addition, 
it has been suggested that Ssb cycles between the cytoplasm and the nucleus and Snl1, which 
is at the ER/nuclear membrane could function as a targeting protein for Ssb at this location to 
enable Ssb to translocate efficiently through pores. Given the complexity of the ribosome 
biogenesis process, further efforts are needed to understand the functions of these chaperones 
in this process. 
  Although association of Snl1 with the ribosome suggests its involvement in protein 
biogenesis, a degradation process exists in yeast that requires the function of the cytosolic 
Hsp70 chaperone, Ssa. Because Snl1 co-purifies Ssa, it is possible that Snl1 may be involved 
in the ER-associated protein degradation (ERAD) pathway, which is a quality control process 
that selectively degrades terminally misfolded or unassembled secretory proteins. The ERAD 
of membrane and soluble proteins requires the 26S proteasome located in the cytosol and 
hence these proteins must be retrotranslocated from the ER to the cytosol. Ssa1 is required 
for the ERAD of several membrane proteins but is dispensable for ERAD of lumenal 
proteins. Snl1 could act as the ER-bound NEF for Ssa1 to maintain the solubility of 
misfolded cytosolic domains on some integral membrane ERAD substrates. This model for 
Snl1 function in ERAD requires further testing. 
 
As observed in (Figure 3-2), in addition to the novel association of Snl1 with the ribosome, 
Fes1 was found to specifically interact with Ssa. The work done in Chapter 5 is a preliminary 
follow-up of my initial discovery and is discussed below. 
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Fes1 has a distinct preference to bind Ssa but not Ssb 
 To determine the binding preference of Fes1 for different types of Hsp70 proteins, I 
performed a co-immunoprecipitation experiment using FLAG-tagged Fes1. Interestingly, I 
found that Fes1 exhibited a strong bias for binding Ssa. This is the first reported evidence of 
an NEF that shows preference for one class of cytosolic Hsp70s in yeast and is in contrast to 
a previously published report that found His6-tagged Fes1 to bind Ssb and perform its 
function of nucleotide exchange in vitro. A major difference in the previous report that 
identified Ssb to bind Fes1 was that recombinant tagged-Fes1 (expressed and purified from 
E. coli) was incubated with cell lysates from yeast and then affinity purified to determine 
Fes1 interacting partners. In the experimental set-up I used, tagged Fes1 was expressed and 
purified from S. cerevisiae before it was incubated with yeast cell lysates. How could the 
Fes1 expression system cause such a stark difference in binding to Ssb? To determine if the 
previous findings were in fact due to whether Fes1 was expressed in E. coli versus S. 
cerevisiae, I purified FLAG-Fes1 from E. coli to near homogeneity and incubated it with 
yeast cell lysate to determine Hsp70 binding partners. I found that Fes1 bound both Ssa and 
Ssb, corroborating previous data and implying that Fes1 produced in S. cerevisiae may be 
post-translationally different than Fes1 made in E. coli.    
What are the conditions that prevent Fes1 made in yeast to interact with Ssb? One 
possible explanation for the lack of Fes1 binding to Ssb is its stoichiometric balance with 
respect to Ssb. Based on the number of protein molecules of Fes1 in the cell (13,100) 
compared to Sse1 (71,700), it could be argued that the abundance of Sse1 in the cell could 
preclude Fes1 from associating with Ssb (45). To test this, I moderately (2-fold) or highly 
(15-20-fold) overproduced Fes1 above chromosomal levels in a wild-type yeast strain to 
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determine if increased Fes1 expression would allow binding to Ssb. This was not the case as 
Fes1 expressed at both levels failed to bind Ssb. This suggests that the abundance of Fes1 in 
the cell is not a determinant for Ssb binding. Another possibility is that Sse1 might prevent 
Fes1 to associate with Ssb even when Fes1 is expressed at high levels in wild type cells. To 
test this, increasing expression levels of Fes1 in sse1Δ cells will determine if Sse1 precludes 
Fes1-Ssb interaction. 
Another possible explanation why Fes1 does not bind Ssb in vivo could be because of 
the ribosome associated complex (RAC), which is known to associate with Ssb and regulate 
its ATPase activity at the ribosome. To test whether Zuo1 and Ssz1, the two components of 
RAC inhibited Fes1-Ssb interaction, I individually expressed and immunopurified tagged-
Fes1 in a strain lacking either ZUO1 or SSZ1 to check if binding to Ssb was restored. From 
this experiment, I concluded that RAC components do not inhibit the interaction of Fes1 with 
Ssb. The other complex situated close to the ribosome exit tunnel and hence in close 
proximity to Ssb, is NAC. Whether Fes1 binds Ssb in the absence of NAC components is yet 
to be determined. 
A third explanation is that Fes1 in yeast is posttranslationally modified. The activity 
and localization of proteins inside the cell can be regulated by reversible posttranslational 
modifications (PTMs) including acetylation, phosphorylation and ubiquitylation, which lead 
to regulation of protein domain activity or mediation of protein-protein interactions. A recent 
publication used mass spectrometry to identify PTMs in proteins and compiled a list of 
nearly 200,000 modification sites across 11 eukaryotic species in order to develop predictors 
of PTM functional relevance (9). When Fes1 was queried in this database, two residues were 
identified for PTM, lysine 16 (predicted ubiquitylated site) and threonine 143 (predicted 
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phosphorylation site). The human homolog HspBP1 was identified to contain one 
ubiquitylation site on residue 94. Further work is needed to test whether mutating these 
residues changes the ability of Fes1 to bind to Ssb in yeast cells.  
Understanding the role of Hsp70 NEFs in difference cellular processes 
Information obtained from the crystal structures of the Hsp70 NEFs and their 
nucleotide exchange mechanisms suggest that despite their different binding modes, most 
NEF families, which include their homologs in other organisms, appear to utilize similar 
nucleotide release mechanisms. The end result is the stabilization of the Hsp70 NBD in an 
open conformation by slightly tilting subdomain IIb. In addition, Sse1 homologs utilize their 
SBD, which exists in an extended conformation to wrap around the distal face of Hsp70. 
Fes1 and its homologs seem to utilize a different mechanism to bind Hsp70 and displace 
bound ADP. These proteins stabilize the outward rotation of subdomain IIb and induce local 
unfolding of lobe I of Hsp70. Structurally, the Hsp70-binding domain of Bag-1 and 
Fes1/HspBP1 are different, the former having a three helix bundle and the latter containing a 
succession of four Armadillo-like repeats (ARM1-ARM4). Each ARM is made of 3 α-
helices that pack into a right-handed superhelix to produce a gently curved elongate molecule 
(Figure 5-1). 
Overexpression of Fes1 or Snl1∆N can rescue an otherwise synthetic sse1∆sse2∆ 
strain suggesting some degree of functional redundancy among the NEFs. The proteins Swi6 
and Swi4 form a heterodimeric transcription factor responsible for cell morphology and is 
activated by the MAP kinase Slt2. Our lab has shown that Sse1 in partnership with Hsp70 
and Hsp90 is required for Slt2 maturation, which in turn is required for signaling through the 
cell wall integrity pathway (128). Loss of both SSE1 and SWI6 causes cells to become 
! 144!
amorphous and elongated and can be suppressed by overexpressing Fes1. This indicates that 
either NEF can partner with Hsp70 to facilitate cell integrity signaling and morphogenesis. 
This redundancy amongst NEFs is not limited to the cytoplasm. Overexpression of 
the ER HspBP1 homolog Sil1 suppresses growth defects of a ire1∆lhs1∆ yeast strain, where 
Lhs1 is the yeast ER Hsp110 homolog and Ire1 is a transmembrane kinase that is essential 
for the unfolded protein response pathway. However, recent experiments to determine which 
NEFs are involved in spindle organization revealed that only Sse1 played a role as an NEF of 
Ssa1/2 to maintain the proper distribution of the widely conserved kinesin-5 motor, Cin8 
within the spindle, which in turn is required for bipolar spindle assembly in S phase. In mice, 
deletion of the ER Hsp110 homolog, Grp170 is lethal and indicates that the alternative NEF 
Sil1 also present in the ER cannot replace the function of Grp170. Mutations in SIL1 disrupt 
Sil1 function resulting in a rare autosomal recessive neurodegenerative disorder called 
Marinesco-Sjögren syndrome that is characterized by the abnormal accumulation of 
ubiquitinated proteins in the ER and nucleus of Purkinje cells of the cerebellum. Grp170 
cannot compensate for these mutations in Sil1. This evidence and other unpublished data 
from our lab suggest that different NEFs can act on Hsp70s with respect to cellular 
substrates. How Hsp70 surveys the available NEFs to determine a binding partner, who then 
enables Hsp70 to interact with its substrate, is still an open question. Specialization of NEFs 
especially BAG domain-containing proteins suggests only partial redundancy among the 
members of this family. These proteins do not seem to be regulators of protein folding by 
Hsp70 but appear to help target Hsp70 for specific functions. Apart from the BAG domain, 
which is a common feature of all Bag proteins, the N-terminal region of these proteins is 
uniquely different and allows individual Bag proteins to interact with distinct target proteins. 
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For instance, all four Bag-1 isoforms along with Bag-6 contain a ubiquitin-like domain and a 
nuclear localization signal, which means that these proteins can enter the nucleus. Bag-3 
contains several tandem proline rich repeats, PXXP, which is a canonical binding domain for 
proteins that contain a Src homology 3 (SH3) motif. These findings indicate that Bag 
proteins may function as adaptor molecules that can recruit molecular chaperones to cellular 
targets through their N-terminal domains and motifs and this alter cellular functions 
including protein degradation, cell proliferation and apoptosis. In line with these findings, I 
have shown that two fungal BAG domain-containing proteins interact with the ribosome and 
suggest that this protein may act as a bridge between protein biogenesis and folding at the ER 
membrane.  
Role of yeast in modeling chaperone function 
Model organisms have been used frequently to determine the functions of chaperones 
in preventing the aggregation of relevant disease-causing proteins. The remarkable homology 
between these organisms has provided many good reasons to use model systems to study 
cellular processes and find targets that will lead to treatments of human disease. For example, 
the etiology of Aβ in Alzheimer’s disease has been the concerted effort of research done 
using fruitflies, worms, budding yeast and mice. It is becoming evident that multiple 
approaches within these model systems will be needed to make significant advances towards 
developing therapies.  
The budding yeast, S. cerevisiae is a good model to study human disease because (i) 
25% of positionally cloned human disease-causing genes has a close yeast homolog and (ii) 
yeast is readily amenable to analysis (7). In addition, 60% of yeast genes have human 
homologs or contain at least one conserved domain with human genes (15, 138). In 1996, the 
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complete genome of S. cerevisiae was sequenced and this lead to the identification of 
orthologs of human genes. Orthologs are genes in different species that are related by vertical 
descent from a common ancestor and normally perform the same function. Thus, yeast has 
been used extensively as a model to dissect the functions of chaperones, which has expanded 
into manipulating the proteostasis network in the cell in order to prevent protein misfolding 
and aggregation. As discussed in chapter 1, there are numerous chaperones involved in 
maintaining protein homeostasis, most of which are evolutionarily conserved from yeast to 
humans. Thus, the roles of chaperones in preventing protein aggregation in the cell can be 
analyzed using in a tractable model organism like yeast. For example, the cooperation of 
different chaperones during polyQ aggregation was tested in a yeast model using sequential 
immunoprecipitations and mass spectrometry to identify proteins associated with an 
aggregation-prone Q103 fragment in the early and late stages following induction of its 
expression (155). Hsp70, Hsp90, Hsp26 and other chaperones interacted with this fragment 
within two hours, followed by partial release of these chaperones prior to the maturation of 
the aggregates and before the recruitment of Hsp104. Use of a small chemical molecule 115-
7c, which stimulates ATP turnover of Hsp70 by favoring its interaction with co-chaperone 
Hsp40 and locking it in the substrate-binding state retained Hsp70 and Hsp90 on the Q103 
fragment and limited the exchange for Hsp104, resulting in incomplete disaggregation and 
suggests that partial release of Hsp70 may be an essential step in expanded polyQ processing 
in yeast. 
Yeast is also becoming an attractive tool in drug discovery. Compound screens have 
led to the successful identification of inhibitors of α-synuclein aggregation and toxicity, 
which may prove to be effective pharmaceutical therapeutics in the future (50). Similarly, 
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compound screens in a yeast model can be used to target chaperones, which can either 
enhance their function and prevent protein aggregation or reduce their function in cases 
involving premature degradation of cellular proteins. For example, mutation of either Hsp70 
or its co-chaperone Ydj1 reduces degradation of CFTR in models of cystic fibrosis (166). 
Consistent with this, co-chaperones that regulate Hsp70 functions are also thought to be 
important in disease. For example, the interaction of Hsp70 with Bag-2 is important for the 
clearance of misfolded tau, involved in Alzheimer’s disease (19). However, there is much 
more work needed to understand chaperone functions, their interacting substrates, how co-
chaperones direct a substrate to them and shape its activities and the cooperation of 
chaperones with the protein degradation machinery to maintain proteostasis. In all these 
cases, the study of chaperones in yeast is proving to be an efficient and quick way to discern 
their functions, which can later be applied to mammalian and human systems.  
Perspectives 
 The genome sequence of S. cerevisiae was completed in 1996 followed by the first 
genome-wide “bar-coded” yeast gene knockout (YKO) mutant collection made available in 
2002, ushering in the era of yeast genomics and proteomics (46). Our understanding of 
protein quality control in cells has been made possible from decades of pathway- and gene-
specific investigations and we now know most of the players involved in maintaining the 
integrity of the cellular proteome. The challenge for the future will be to determine how these 
components interact and how they are organized into functional networks to promote the life 
of a cell. This knowledge can then be translated to understanding similar questions in human 
cells, with the key goal to devise methods to modulate the network to further human health.     
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 Identification of a function of Snl1 in yeast cells with relation to its interaction with 
ribosomes has been hindered due to the lack of a detectable phenotype associated with loss of 
SNL1. Studies involving genetic interactions have been extremely useful to characterize gene 
function and identifying pathways that the gene product is involved in the cell. Previously, 
systematic analysis of genome-wide gene-gene synthetic lethality interactions has provided 
an effective way to study gene functions but have been unsuccessful with identifying a 
pathway-specific function for SNL1 (146). A new technique, dSLAM (heterozygous diploid-
based synthetic lethality analysis on microarrays) has been developed that combines 
heterozygous diploid YKO mutants in pooled form and the efficiency of a microarray 
analysis of abundance of YKOs in the population (100). For each YKO, its relative growth 
rate as a single and double mutant (in combination with SNL1) can be indirectly compared by 
microarray analysis of the abundance of “bar-codes” in both the haploid single (control) and 
double (experiment) mutant pools. This technique may deliver a set of putative interactors of 
SNL1 to test. Another approach that would enable potential capture of Snl1-dependent 
substrates during protein translation is ribosome profiling. This approach maps the position 
of ribosomes on mRNA transcripts by nuclease footprinting. The abundance of various 
footprint fragments in deep sequencing data will indicate the amount of translation of a gene 
(61). This technique was used previously to quantitatively monitor translation rates and to 
identify when the E. coli ribosome-associated chaperone trigger factor engages polypeptides 
(97). Since we have shown that membrane associated Snl1 can efficiently bind ribosomes, 
selective profiling of ribosomes that are bound to Snl1 and affinity purified from yeast cells 
may enable the identification of mRNA transcripts being translated by ribosomes bound by 
Snl1. Thus, these global analyses using genetic and biochemical approaches should help to 
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discern a functional role for Snl1. Future efforts to determine the coordinated action of 
various ribosome-associated chaperones, processing enzymes and targeting factors that 
ensure the efficient biogenesis of cellular proteins is warranted. In line with this, kinetic flux 
of newly synthesized proteins that transit through the cytosolic Hsp70s, Ssa and Ssb, and 
their NEFs can be determined using pulse chase analysis. This technique was used previously 
to show the transient rate of association of Sse1, Ssa and Ssb with newly synthesized 
polypeptides during de novo folding and the effect of the loss of SSB on chaperone utilization 
during translation.  (163). A similar approach may provide additional insights into the role of 
Snl1 in cellular protein biogenesis.  
 Eukaryotic cells employ a number of complex targeting pathways to efficiently and 
accurately deliver nascent polypeptides to organelles. Hsp70 and Hsp90 chaperones are 
utilized for targeting to mitochondria and chloroplasts and receptors capable of recognizing 
these chaperones have been identified on the surface of both organelles (36, 132). Although 
the role of these receptors is not fully understood, they may help to increase the efficiency of 
protein targeting. It is also less clear whether these membrane receptors contribute to 
targeting specificity. Since Hsp70 is involved in targeting to many cellular organelles, 
targeting to a cellular localization must be more than a substrate recognition event. For 
instance, a single chaperone or a combination of chaperones may function in tandem to 
properly deliver a substrate to its precise location in the cell. If this is true, how is targeting 
regulated and how do co-chaperones play a role? The localization of Snl1 at the ER 
membrane and its ability to bind ribosomes and Hsp70 independent of the other suggests that 
this BAG domain-containing protein may serve as a targeting receptor for Hsp70 in yeast 
cells. Targeting tail-anchored (TA) membrane proteins to the ER in yeast was shown to 
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require a highly coordinated sequence of events and involved a conserved set of proteins. 
This guided entry of TA proteins (GET) pathway was shown to be independent of the well-
studied signal recognition particle (SRP) complex-dependent pathway. It is possible that 
ribosomes translating TA proteins may be associated with Snl1, which then recruits Hsp70 to 
the ER for substrate folding. Loss of GET complex components leads to mislocalization of a 
number of TA proteins including Sbh1/2 and Scs2 (126). Proper ER localization of these 
fluorescent-tagged proteins can be tested in snl1Δ cells and can be complemented by the 
Hsp70- and ribosome- binding mutants of Snl1 to determine whether either binary complex 
is involved in this pathway. A key step in the GET pathway is formation of a complex 
between Get3 and the TA protein being translated. Unlike SRP, Get3 does not associate with 
ribosomes (76) and it remains unclear whether this protein surveys all TA proteins and 
commits only ER-bound ones or whether TA protein-containing signals are sorted at an 
earlier step. It is possible that Snl1 present at the ER membrane and associated with 
translating ribosomes could assist in Get3 detection of its substrates. 
 One area ripe for further investigation involves identifying the coordinated functions 
of NEFs and J domain-containing proteins in Hsp70 regulation. In yeast cells, the cytosol 
contains 11 J proteins and three NEFs. The functional overlap and differences between these 
co-chaperones for specific substrates is an active area for research. For example, it has been 
shown that the Hsp70 co-chaperone Ydj1 possesses a C-terminal CAAX sequence, where A 
is an aliphatic amino acid and X is any residue, and this sequence specifies the addition of a 
farnesyl modification group to Ydj1, which converts the cytosolic protein to one that can 
attach to the ER and perinuclear membranes (18). It is tempting to speculate that under 
certain cellular conditions, farnesylation of Ydj1 may target it to the cytosolic face of the ER 
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membrane, which along with Snl1 could enhance Hsp70-dependent folding at this specific 
location. This modification has been shown to have specific roles in protein-protein 
interactions, particularly those that facilitate protein trafficking and subcellular localization 
(137). Further, the specific Snl1 binding site on the ribosome and how its interaction is 
coordinated with several other ribosome-associated factors including SRP, NAC complex 
and RAC complex remain important questions for future studies.  
 Fes1 and Ydj1 have been suggested to play antagonistic functions with regard to their 
respective negative and positive regulation of Ssa1 ATPase activity (63). However, it is not 
clear whether these two proteins compete for binding to Ssa1 or if substrates regulate the 
temporal interaction of Ssa1 with its co-chaperones. An ab initio construction of the S. 
cerevisiae transcriptome by parallel mRNA sequencing identified a previously 
uncharacterized intron in the FES1 gene with full reads through the splice junction and inside 
the intron, suggesting alternative splicing (165). In the spliced variant, the annotated stop 
codon is removed and a later stop codon is introduced resulting in a 10 amino acid extension, 
which was validated by RT-PCR showing bands consistent with both forms. It is therefore 
possible that under certain conditions, unknown at present, Fes1 is available in an alternate 
form, which then dictates its Hsp70-binding function. It will be interesting to discern whether 
spliced Fes1 could play a role in Fes1 interaction with Ssb. HspBP1, the Fes1 homolog in 
human cells, is the least efficient NEF as measured by ADP dissociation constants in vitro, 
and is inhibitory of Hsc70 refolding function (150). In addition, HspBP1 was shown to 
promote degradation of proteins and block anti-apoptotic functions of stress-induced Hsp70. 
These findings are consistent with HspBP1 acting as an inhibitor of Hsp70, possibly as a 
function of relative NEF/70 stoichiometry (3, 145). It seems likely that cytosolic NEFs can 
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accommodate three functions: Fes1 and its homologs inhibit Hsp70 and may be utilized 
when protein degradation as opposed to protein refolding is a better survival strategy for 
cells. The Sse family is the strongest activator of Hsp70 ATPase and may be better suited to 
assist in refolding. The ability of Snl1 and its homologs to associate with other functional 
domains in proteins suggests a more specialized role for these NEFs in Hsp70 targeting and 
recruitment.  
 The Hsp70 chaperone system has been subject to intense evaluation for a number of 
years with regard to identifying components and pathways that are required to maintain 
homeostasis of the cellular proteome. The next decade or more will be focused on identifying 
how these components and pathways are interconnected to promote cellular survival under 
normal and stress conditions and in designing pharmacological chaperones to modulate these 
pathways. I anticipate that a combined effort by various groups using different model 
organisms will help to understand these networks and will be key to elucidating their in vivo 
functional significance. 
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